Referensi Tuberkulosis T-X

 

1. Tan, Q., Huang, C.C., Calderon, R., Lecca, L., Mendoza, M., Rocha, G.R., Tintaya, K., Tovar, X., Feng, J.Y., Pan, S.W. and Tseng, Y.H., 2025. Microbiological aspects and clinical impact of lower lung field tuberculosis: An observational cohort study in Peru. International Journal of Infectious Diseases, 150, p.107284.
2. Taniguchi, J., Jo, T., Aso, S., Matsui, H., Fushimi, K. and Yasunaga, H., 2024. Safety of pyrazinamide in elderly patients with tuberculosis in Japan: A nationwide cohort study. Respirology, 29(10), pp.905-913.
3. Tariq, M., Zafar, S., Waheed, A., Afzal, N., Razzaq, R. and Batool, F., 2023. Prevalence of Various Forms of Active Tuberculosis in Patients with Diabetes. THE THERAPIST (Journal of Therapies & Rehabilitation Sciences), pp.33-37.
4. Tavitian-Exley, I., Kyaw, W.M., Kang-Yang, L.L., Foo, K., Boudville, I.C., Cutter, J.L. and Ng, D.H.L., 2024. Risk factors for tuberculosis among close IGRA-negative contacts of persons with infectious tuberculosis in Singapore. International Journal of Infectious Diseases, 147, p.107166.
5. Taylor, J., Bastos, M.L., Lachapelle-Chisholm, S., Mayo, N.E., Johnston, J. and Menzies, D., 2023. Residual respiratory disability after successful treatment of pulmonary tuberculosis: a systematic review and meta-analysis. EClinicalMedicine, 59.
6. Teo, A.K.J., Morishita, F., Islam, T., Viney, K., Ong, C.W., Kato, S., Kim, H., Liu, Y., Oh, K.H., Yoshiyama, T. and Ohkado, A., 2023. Tuberculosis in older adults: challenges and best practices in the Western Pacific Region. The Lancet Regional Health-Western Pacific, 36, p.100770.
7. Thipkrua, N., Disrathakit, A., Chongsuvivatwong, V., Mahasirimongkol, S., Ruangchai, W., Palittapongarnpim, P., Chaiprasert, A., Pungrassami, P., Kamolwat, P., Suthum, K. and Tossapornpong, K., 2025. A large geno-spatial cluster of multi-drug resistant tuberculosis outbreak in a western district of Thailand. Infection, Genetics and Evolution, 128, p.105715.
8. Trevisi, L., Brooks, M.B., Becerra, M.C., Calderón, R.I., Contreras, C.C., Galea, J.T., Jimenez, J., Lecca, L., Yataco, R.M., Tovar, X. and Zhang, Z., 2024. Who transmits tuberculosis to whom: a cross-sectional analysis of a cohort study in Lima, Peru. American Journal of Respiratory and Critical Care Medicine, 210(2), pp.222-233.
9. Turyahabwe, S., Bamuloba, M., Mugenyi, L., Amanya, G., Byaruhanga, R., Imoko, J.F., Nakawooya, M., Walusimbi, S., Nidoi, J., Burua, A. and Sekadde, M., 2024. Community tuberculosis screening, testing and care, Uganda. Bulletin of the World Health Organization, 102(6), p.400.
10. Ugwu, C.I., Chukwulobelu, U., Igboekwu, C., Emodi, N., Anumba, J.U., Ugwu, S.C., Ezeobi, C.L., Ibeziako, V. and Nwakaogor, G.U., 2021. Geo-spatial mapping of tuberculosis burden in Anambra State, South-East Nigeria. Journal of Tuberculosis Research, 9(01), p.51.
11. Ullah, W., Wali, A., Haq, M.U., Yaqoob, A., Fatima, R. and Khan, G.M., 2021. Public–private mix models of tuberculosis care in Pakistan: a high-burden country perspective. Frontiers in public health, 9, p.703631.
12. Vaishya R, Misra A, Vaish A, Singh SK. Diabetes and tuberculosis syndemic in India: A narrative review of facts, gaps in care and challenges. J Diabetes. 2024 May;16(5):e13427.
13. van Crevel, R.; Critchley, J.A. The Interaction of Diabetes and Tuberculosis: Translating Research to Policy and Practice. Trop. Med. Infect. Dis. 2021, 6, 8.
14. van Lieshout Titan, A., Dodd, P.J., Cohen, T. and Menzies, N.A., 2026. Estimating the number of incorrect tuberculosis diagnoses in low-and middle-income countries. Nature Medicine, pp.1-8.
15. Van Wyk, S.S., Lin, H.H. and Claassens, M.M., 2017. A systematic review of prediction models for prevalent pulmonary tuberculosis in adults. The International Journal of Tuberculosis and Lung Disease, 21(4), pp.405-411.
16. Varotto, E., Martini, M., Vaccarezza, M., Vittori, V., Mietlińska-Sauter, J., Gelsi, R., Galassi, F.M. and Papa, V., 2025. Historical and Social Considerations upon Tuberculosis. Journal of Preventive Medicine and Hygiene, 66(1), pp.E145-E152.
17. Vesga, J.F., Hallett, T.B., Reid, M.J., Sachdeva, K.S., Rao, R., Khaparde, S., Dave, P., Rade, K., Kamene, M., Omesa, E. and Masini, E., 2019. Assessing tuberculosis control priorities in high-burden settings: a modelling approach. The Lancet Global Health, 7(5), pp.e585-e595.
18. Viswanathan, V., Devarajan, A., Kumpatla, S., Dhanasekaran, M., Babu, S. and Kornfeld, H., 2023. Effect of prediabetes on tuberculosis treatment outcomes: A study from South India. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 17(7), p.102801.
19. Wang C-A, Chen C-H, Hsieh W-C, Hsu T-J, Hsu C-Y, Cheng Y-C, Hsu C-Y. Risk of Herpes Zoster in Patients with Pulmonary Tuberculosis—A Population-Based Cohort Study. International Journal of Environmental Research and Public Health. 2023; 20(3):2656.
20. Wang C, Yang X, Zhang H, Zhang Y, Tao J, Jiang X and Wu C (2023) Temporal trends in mortality of tuberculosis attributable to high fasting plasma glucose in China from 1990 to 2019: a joinpoint regression and age-period-cohort analysis. Front. Public Health 11:1225931.
21. Wang, J., Yu, L., Yang, Z., Shen, P., Sun, Y., Shui, L., Tang, M., Jin, M., Chen, B., Ge, Y. and Lin, H., 2025. Development of chronic obstructive pulmonary disease after a tuberculosis episode in a large, population-based cohort from Eastern China. International journal of epidemiology, 54(2), p.dyae174.
22. Wang, M.C. and Cervantes, J., 2019. Glycemic control in tuberculosis: lessons learned from Taiwan. Asian Pacific Journal of Tropical Medicine, 12(10), pp.438-441.
23. Wang, S., Gu, R., Ren, P., Chen, Y., Wu, D. and Li, L., 2025. Prediction of tuberculosis-specific mortality for older adult patients with pulmonary tuberculosis. Frontiers in Public Health, 12, p.1515867.
24. Wang, Y., Shi, J., Yin, X., Tao, B., Shi, X., Mao, X., Wen, Q., Xue, Y. and Wang, J., 2024. The impact of diabetes mellitus on tuberculosis recurrence in Eastern China: a retrospective cohort study. BMC Public Health, 24(1), p.2534.
25. Wati, N., Mu’awanah, I.A.U. and Amalia, A.A., 2024. Pulmonary Tuberculosis Incidence Rate with Genexpert Examination Method at Mlati II Public Health Center, Sleman In 2020-2023. International Journal of Health, Economics, and Social Sciences, 6(4), pp.1124-1129.
26. Webber, T., Ronacher, K., Conradie-Smit, M. and Kleynhans, L., 2022. Interplay between the immune and endocrine systems in the lung: implications for TB susceptibility. Frontiers in immunology, 13, p.829355.
27. Wells, W.A., Waseem, S. and Scheening, S., 2024. The intersection of TB and health financing: defining needs and opportunities. IJTLD open, 1(9), pp.375-383.
28. Whitworth, H.S., Badhan, A., Boakye, A.A., Takwoingi, Y., Rees-Roberts, M., Partlett, C., Lambie, H., Innes, J., Cooke, G., Lipman, M. and Conlon, C., 2019. Clinical utility of existing and second-generation interferon-γ release assays for diagnostic evaluation of tuberculosis: an observational cohort study. The Lancet Infectious Diseases, 19(2), pp.193-202.
29. Widihastuti, A., Sirait, R.H., Simatupang, A. and Idhayu, A.T., 2023. Effect of Poor Glycemic Control with Length of Pulmonary Tuberculosis Treatment in Type 2 Diabetes Mellitus Patients. Jurnal Farmasi Klinik Indonesia, 12(1), pp.1-10.
30. Williams, V., Onwuchekwa, C., Vos, A.G., Grobbee, D.E., Otwombe, K. and Klipstein-Grobusch, K., 2022. Tuberculosis treatment and resulting abnormal blood glucose: a scoping review of studies from 1981-2021. Global Health Action, 15(1), p.2114146.
31. Wright K. Tackling Tuberculosis: The Current Landscape and Future Directions. EMJ Microbiol Infect Dis. 2025;6[1]:26-30.
32. Wu, Y., Wang, C. and Li, Y., 2025. Status and outlook of pulmonary tuberculosis coinfection. Journal of Research in Medical Sciences, 30(1), p.34.
33. Wulandari, D.A., Hartati, Y.W., Ibrahim, A.U. and Pitaloka, D.A.E., 2024. Multidrug-resistant tuberculosis. Clinica Chimica Acta, 559, p.119701.
34. Xiao, J., Ge, J., Zhang, D., Lin, X., Wang, X., Peng, L. and Chen, L., 2022. Clinical characteristics and outcomes in chronic kidney disease patients with tuberculosis in China: A retrospective cohort study. International Journal of General Medicine, 15, p.6661.
35. Xiong, X.S., Zhang, X.D., Yan, J.W., Huang, T.T., Liu, Z.Z., Li, Z.K., Wang, L. and Li, F., 2024. Identification of Mycobacterium tuberculosis resistance to common antibiotics: an overview of current methods and techniques. Infection and Drug Resistance, pp.1491-1506.
36. Xu, G., Hu, X., Lian, Y. and Li, X., 2023. Diabetes mellitus affects the treatment outcomes of drug-resistant tuberculosis: a systematic review and meta-analysis. BMC Infectious Diseases, 23(1), p.813.

Referensi Tuberkulosis A-B

1. Abbas, U., Masood, K.I., Khan, A., Irfan, M., Saifullah, N., Jamil, B. and Hasan, Z., 2022. Tuberculosis and diabetes mellitus: Relating immune impact of co-morbidity with challenges in disease management in high burden countries. Journal of clinical tuberculosis and other mycobacterial diseases, 29, p.100343.
2. Abdullahi, L.H., Oketch, S., Komen, H., Mbithi, I., Millington, K., Mulupi, S., Chakaya, J. and Zulu, E.M., 2024. Gendered gaps to tuberculosis prevention and care in Kenya: a political economy analysis study. BMJ open, 14(4), p.e077989.
3. Adam, N., Pallikadavath, S., Cerasuolo, M. and Amos, M., 2021. Investigating the risk factors for contraction and diagnosis of human tuberculosis in Indonesia using data from the fifth wave of RAND’s Indonesian Family Life Survey (IFLS-5). Journal of Biosocial Science, 53(4), pp.577-589.
4. Adane, H.T., Howe, R.C., Wassie, L. and Magee, M.J., 2023. Diabetes mellitus is associated with an increased risk of unsuccessful treatment outcomes among drug-susceptible tuberculosis patients in Ethiopia: A prospective health facility-based study. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 31, p.100368.
5. Ajudua, F.I. and Mash, R.J., 2024. Implementing active surveillance for TB: A descriptive survey of healthcare workers in the Eastern Cape, South Africa. African Journal of Primary Health Care & Family Medicine, 16(1), p.4217.
6. Akinshipe, B.O., Yusuf, E.O., Akinshipe, F.O., Moronkeji, M.A. and Nwaobi, A.C., 2019. Prevalence and Determinants of Pre-diabetes and Latent Tuberculosis Infection Among Apparently Healthy Adults in Three Communities in Southern Nigeria. International Journal of Immunology, 7(2), pp.23-32.
7. Al-Bari MAA, Peake N, Eid N. Tuberculosis-diabetes comorbidities: Mechanistic insights for clinical considerations and treatment challenges. World J Diabetes 2024; 15(5): 853-866.
8. Alemu, A., Diriba, G., Seid, G., Wondimu, A., Moga, S., Tadesse, G., Haile, B., Berhe, N., Mariam, S.H. and Gumi, B., 2025. Active tuberculosis among patients with presumptive tuberculosis with chronic kidney disease in a high tuberculosis burden country, Ethiopia: a multi-center study. IJID regions, 14, p.100551.
9. Alemu, A., Seid, G., Diriba, G., Hailu, M., Dange, B., Moga, S., Melese, D., Tadesse, G., Mariam, S.H., Berhe, N. and Gumi, B., 2025. Prevalence and associated factors of tuberculosis among diabetic patients attending public health facilities in Ethiopia: a multicenter study. Archives of Public Health, 83(1), pp.1-15.
10. Alisjahbana, B., Sahiratmadja, E., Nelwan, E.J., Purwa, A.M., Ahmad, Y., Ottenhoff, T.H., Nelwan, R.H., Parwati, I., Meer, J.W.V.D. and Crevel, R.V., 2007. The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clinical infectious diseases, 45(4), pp.428-435.
11. Alma, L.R., Olivionita, V. and Wardani, H.E., 2024. An Ecological Study of Determinants of The Incidence of Tuberculosis in Malang Raya Area. Preventia: The Indonesian Journal of Public Health, 9(1), 112–120.
12. Almeida-Junior JL, Gil-Santana L, Oliveira CAM, Castro S, Cafezeiro AS, Daltro C, et al. (2016) Glucose Metabolism Disorder Is Associated with Pulmonary Tuberculosis in Individuals with Respiratory Symptoms from Brazil. PLoS ONE 11(4):e0153590.
13. Alvarado-Valdivia, N.T., Flores, J.A., Inolopú, J.L. and Rosales-Rimache, J.A., 2024. Type 2 diabetes mellitus and recurrent Tuberculosis: A retrospective cohort in Peruvian military workers. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 35, p.100432.
14. Amelia, G. and Suryanto, J., 2024. Sensitivity Analysis of Diabetes Mellitus and Tuberculosis for Confounders: A Comprehensive Systematic Review. The Indonesian Journal of General Medicine, 1(1), pp.28-45.
15. Antonio-Arques, V., Caylà, J.A., Real, J., Moreno-Martinez, A., Orcau, À., Mauricio, D., Mata-Cases, M., Julve, J., Navas Mendez, E., Puig Treserra, R. and Millet, J.P., 2022. Glycemic control and the risk of tuberculosis in patients with diabetes: A cohort study in a Mediterranean city. Frontiers in public health, 10, p.1017024.
16. Araia, Z.Z., Mesfin, A.B., Mebrahtu, A.H., Tewelde, A.G., Osman, R. and Tuumzghi, H.A., 2021. Diabetes mellitus and its associated factors in tuberculosis patients in maekel region, eritrea: analytical cross-sectional study. Diabetes, Metabolic Syndrome and Obesity, pp.515-523.
17. Araujo-Pereira, M., Vinhaes, C.L., Barreto-Duarte, B., Villalva-Serra, K., Queiroz, A.T.L., & Andrade, B.B. (2024). Intersecting epidemics: Deciphering the complexities of tuberculosis-diabetes comorbidity. Frontiers in Tuberculosis, 2, Article 1487793. 
18. Aravindhan, V. and Yuvaraj, S., 2024. Immune-endocrine network in diabetes-tuberculosis nexus: does latent tuberculosis infection confer protection against meta-inflammation and insulin resistance?. Frontiers in Endocrinology, 15, p.1303338.
19. Arriaga, M.B., Araújo-Pereira, M., Barreto-Duarte, B., Nogueira, B., Freire, M.V.C., Queiroz, A.T., Rodrigues, M.M., Rocha, M.S., Souza, A.B., Spener-Gomes, R. and Carvalho, A.C.C., 2022. The effect of diabetes and prediabetes on antituberculosis treatment outcomes: a multicenter prospective cohort study. The Journal of Infectious Diseases, 225(4), pp.617-626.
20. Arriaga, M.B., Rocha, M.S., Nogueira, B.M., Nascimento, V., Araújo-Pereira, M., Souza, A.B., Andrade, A.M., Costa, A.G., Gomes-Silva, A., Silva, E.C. and Figueiredo, M.C., 2021. The effect of diabetes and prediabetes on Mycobacterium tuberculosis transmission to close contacts. The Journal of Infectious Diseases, 224(12), pp.2064-2072.
21. Baik, Y., Rickman, H.M., Hanrahan, C.F., Mmolawa, L., Kitonsa, P.J., Sewelana, T., Nalutaaya, A., Kendall, E.A., Lebina, L., Martinson, N. and Katamba, A., 2020. A clinical score for identifying active tuberculosis while awaiting microbiological results: development and validation of a multivariable prediction model in sub-Saharan Africa. PLoS medicine, 17(11), p.e1003420.
22. Baker, M.A., Lin, H.H., Chang, H.Y. and Murray, M.B., 2012. The risk of tuberculosis disease among persons with diabetes mellitus: a prospective cohort study. Clinical Infectious Diseases, 54(6), pp.818-825.
23. Bao, J., Hafner, R., Lin, Y., Lin, H.H. and Magee, M.J., 2018. Curbing the tuberculosis and diabetes co-epidemic: strategies for the integration of clinical care and research. The International Journal of Tuberculosis and Lung Disease, 22(10), pp.1111-1112.
24. Barberis, I., Bragazzi, N.L., Galluzzo, L. and Martini, M., 2017. The history of tuberculosis: from the first historical records to the isolation of Koch’s bacillus. Journal of Preventive Medicine and Hygiene, 58(1), pp.E9-E12.
25. Barron, M.M., Shaw, K.M., Bullard, K.M., Ali, M.K. and Magee, M.J., 2018. Diabetes is associated with increased prevalence of latent tuberculosis infection: Findings from the National Health and Nutrition Examination Survey, 2011–2012. Diabetes research and clinical practice, 139, pp.366-379.
26. Basham CA, Smith SJ, Romanowski K, Johnston JC (2020). Cardiovascular morbidity and mortality among persons diagnosed with tuberculosis: A systematic review and meta-analysis. PLoS ONE, 15(7), e0235821.
27. Bezerra, A.L., Moreira, A.D.S.R., Isidoro-Gonçalves, L., Lara, C.F.D.S., Amorim, G., Silva, E.C., Kritski, A.L. and Carvalho, A.C.C., 2022. Clinical, laboratory, and radiographic aspects of patients with pulmonary tuberculosis and dysglycemia and tuberculosis treatment outcomes. Jornal Brasileiro de Pneumologia, 48(06), p.e20210505.
28. Bhatia, V., Rijal, S., Sharma, M., Islam, A., Vassall, A., Bhargava, A., Thida, A., Basri, C., Onozaki, I., Pai, M. and Rezwan, M.K., 2023. Ending TB in South-East Asia: flagship priority and response transformation. The Lancet Regional Health-Southeast Asia, 18.
29. Bhatia V, Srivastava R, Reddy KS, et al. Ending TB in Southeast Asia: current resources are not enough. BMJ Global Health 2020;5:e002073. doi:10.1136/ bmjgh-2019-002073.
30. Bian, Q., Zhang, Y., Xue, C., Lu, W., Li, W., Pan, F. and Li, Y., 2024. Global and regional estimates of tuberculosis burden attributed to high fasting plasma glucose from 1990 to 2019: emphasis on earlier glycemic control. BMC Public Health, 24(1), p.782.
31. Bigio, J., Viscardi, A., Gore, G., Matteelli, A. and Sulis, G., 2023. A scoping review on the risk of tuberculosis in specific population groups: can we expand the World Health Organization recommendations?. European Respiratory Review, 32(167).
32. Bisht MK, Dahiya P, Ghosh S and Mukhopadhyay S (2023) The cause-effect relation of tuberculosis on incidence of diabetes mellitus. Front. Cell. Infect. Microbiol.
33. Boadu, A.A., Yeboah-Manu, M., Osei-Wusu, S. and Yeboah-Manu, D., 2024. Tuberculosis and diabetes mellitus: The complexity of the comorbid interactions. International Journal of Infectious Diseases, p.107140.
34. Brake, J., Ajie, M., Sumpter, N.A., Koesoemadinata, R.C., Soetedjo, N.N., Santoso, P., Alisjahbana, B., Ruslami, R., Hill, P. and van Crevel, R., 2025. Inflammation and dyslipidaemia in combined diabetes and tuberculosis; a cohort study. iScience, 28(6).
35. Brooks, M.B., Lecca, L., Becerra, M.C., Calderon, R.I., Contreras, C.C., Jimenez, J., Yataco, R.M., Zhang, Z., Murray, M.B. and Huang, C.C., 2025. The Role of Youths in Within-Household Tuberculosis Transmission: A Household Contact Cohort Study. Clinical Infectious Diseases, p.ciaf490.
36. Buasroung, P., Petnak, T., Liwtanakitpipat, P. and Kiertiburanakul, S., 2022. Prevalence of diabetes mellitus in patients with tuberculosis: a prospective cohort study. International Journal of Infectious Diseases, 116, pp.374-379.
37. Bumbu, L., Vaccher, S., Holmes, A., Sodeng, K., Graham, S.M. and Lin, Y.D., 2024. Drug-resistant TB in Morobe Province, Papua New Guinea, 2012–2021. Public Health Action, 14(4), pp.146-151.
38. Buryanti, S., 2021. Faktor-Faktor yang Mempengaruhi Kejadian TB MDR di Kota Semarang. Journal Health & Science: Gorontalo Journal Health and Science Community, 5(1), pp.146-154.
39. Byers, M.; Guy, E. The Complex Relationship Between Tuberculosis and Hyperglycemia. Diagnostics 2024, 14, 2539.

Referensi Tuberkulosis M

1. Ma, J.J., Guo, Y.J., Li, Z., Chen, Y., He, H. and Li, W.M., 2022. Prevalence and prognostic significance of malnutrition risk in patients with pulmonary tuberculosis: a hospital-based cohort study. Frontiers in Public Health, 10, p.1039661.
2. Madaki, S., Mohammed, Y., Rogo, L.D., Yusuf, M. and Bala, Y.G., 2024. Age and gender in drug resistance tuberculosis: a cross-sectional case study at a national tuberculosis reference hospital in Nigeria. Journal of Global Antimicrobial Resistance, 39, pp.175-183.
3. Mafirakureva, N., Cartledge, A., Bradshaw, I., Bekker, A., Salazar-Austin, N., Meehan, S.A., Myer, L., Odayar, J., Rangaka, M.X. and Dodd, P.J., 2026. Global estimates of tuberculosis incidence during pregnancy and postpartum: a rapid review and modelling analysis. The Lancet Global Health.
4. Magee, M.J., Salindri, A.D., Gujral, U.P., Auld, S.C., Bao, J., Haw, J.S., Lin, H.H. and Kornfeld, H., 2018. Convergence of non-communicable diseases and tuberculosis: a two-way street?. The International Journal of Tuberculosis and Lung Disease, 22(11), pp.1258-1268.
5. Magee, M.J., Trost, S.L., Salindri, A.D., Amere, G., Day, C.L. and Gandhi, N.R., 2020. Adults with Mycobacterium tuberculosis infection and pre-diabetes have increased levels of QuantiFERON interferon-gamma responses. Tuberculosis, 122, p.101935.
6. Magodoro, I., Kotze, L., Stek, C.J., West, A., Le Roux, A., Sobratee, N., Taliep, A., Hamada, Y., Dave, J.A., Rangaka, M.X. and Parihar, S.P., 2025. Clinical, metabolic and immune interaction between tuberculosis and diabetes mellitus: implications and opportunities for therapies. Expert Opinion on Pharmacotherapy.
7. Magodoro, I.M., Aluoch, A., Claggett, B., Nyirenda, M.J., Siedner, M.J., Wilkinson, K.A., Wilkinson, R.J. and Ntusi, N.A., 2024, October. Association Between Mycobacterium tuberculosis Sensitization and Insulin Resistance Among US Adults Screened for Type 2 Diabetes Mellitus. In Open Forum Infectious Diseases (Vol. 11, No. 10, p. ofae568). US: Oxford University Press.
8. Majaliwa, E.S., Muze, K., Godfrey, E., Byashalira, K., Mmbaga, B.T., Ramaiya, K. and Mfinanga, S.G., 2023. Latent tuberculosis in children and youth with type 1 diabetes mellitus in Dar es Salaam, Tanzania: a cross section survey. BMC Infectious Diseases, 23(1), p.740.
9. Makrufardi, F., Chuang, H.C., Suk, C.W., Lin, Y.C., Rusmawatiningtyas, D., Murni, I.K., Arguni, E., Chung, K.F. and Bai, K.J., 2024. Particulate matter deposition and its impact on tuberculosis severity: A cross-sectional study in Taipei. Science of the Total Environment, 924, p.171534.
10. Mandal, S., Bhatia, V., Bhargava, A., Rijal, S. and Arinaminpathy, N., 2024. The potential impact on tuberculosis of interventions to reduce undernutrition in the WHO South-East Asian Region: a modelling analysis. The Lancet Regional Health-Southeast Asia, p.100423.
11. Mangamba, L.M.E., Halle, M.P., Onana, C.L.M., Tochie, J.N., Ngamby, V., Noubibou, J.C.E., Balkissou, A.D., Tewaffeu, D.G., & Ngahane, B.H.M. (2023). Impact of Chronic Kidney Disease on the Mortality of Tuberculosis Patients: A Cross-Sectional Study in Douala. Health Sciences and Disease, 24(2).
12. Manjourides, J., Lin, H.H., Shin, S., Jeffery, C., Contreras, C., Santa Cruz, J., Jave, O., Yagui, M., Asencios, L., Pagano, M. and Cohen, T., 2012. Identifying multidrug resistant tuberculosis transmission hotspots using routinely collected data. Tuberculosis, 92(3), pp.273-279.
13. Mao, J.J., Zang, X., Yue, W.L., Zhai, P.Y., Zhang, Q., Li, C.H., Zhuang, X., Liu, M. and Qin, G., 2023. Population-level health and economic impacts of introducing Vaccae vaccination in China: a modelling study. BMJ global health, 8(5), p.e012306.
14. Marme, G., Kuzma, J., Zimmerman, P.A., Harris, N. and Rutherford, S., 2024. Investigating socio-ecological factors influencing implementation of tuberculosis infection prevention and control in rural Papua New Guinea. Journal of Public Health, 46(2), pp.267-276.
15. Martinez, L., Zhu, L., Castellanos, M.E., Liu, Q., Chen, C., Hallowell, B.D. and Whalen, C.C., 2017. Glycemic control and the prevalence of tuberculosis infection: a population-based observational study. Clinical Infectious Diseases, 65(12), pp.2060-2068.
16. Matteelli, A., Churchyard, G., Cirillo, D., den Boon, S., Falzon, D., Hamada, Y., Houben, R.M., Kanchar, A., Kritski, A., Kumar, B. and Miller, C., 2024. Optimizing the cascade of prevention to protect people from tuberculosis: A potential game changer for reducing global tuberculosis incidence. PLOS Global Public Health, 4(7), p.e0003306.
17. McQuaid, C.F., Clark, R.A., White, R.G., Bakker, R., Alexander, P., Henry, R., Velayutham, B., Muniyandi, M., Sinha, P., Bhargava, M. and Bhargava, A., 2025. Estimating the epidemiological and economic impact of providing nutritional care for tuberculosis-affected households across India: a modelling study. The Lancet Global Health.
18. Meghji, J., Kon, O.M. and Ainley, A., 2023. Clinical tuberculosis. Medicine, 51(11), pp.768-773.
19. Mendelsohn, S.C., Fiore-Gartland, A., Awany, D., Mulenga, H., Mbandi, S.K., Tameris, M., Walzl, G., Naidoo, K., Churchyard, G., Scriba, T.J. and Hatherill, M., 2022. Clinical predictors of pulmonary tuberculosis among South African adults with HIV. EClinicalMedicine, 45.
20. Meng F, Lan L, Wu G, Ren X, Yuan X,Yang M, Chen Q, Peng X and Liu D (2023). Impact of diabetes itself and glycemic control status on tuberculosis. Front. Endocrinol. 14:1250001.
21. Menzies, N.A., Cohen, T., Lin, H.H., Murray, M. and Salomon, J.A., 2012. Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation. PLoS medicine, 9(11), p.e1001347.
22. Menzies, N.A., Gomez, G.B., Bozzani, F., Chatterjee, S., Foster, N., Baena, I.G., Laurence, Y.V., Qiang, S., Siroka, A., Sweeney, S. and Verguet, S., 2016. Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models. The Lancet global health, 4(11), pp.e816-e826.
23. Menzies, N.A., Brown, T.S., Imai-Eaton, J.W., Dodd, P.J., Cohen, T. and Martinez, L., 2025. Potential paediatric tuberculosis incidence and deaths resulting from interruption in programmes supported by international health aid, 2025–34: a mathematical modelling study. The Lancet Child & Adolescent Health, 9(11), pp.787-795.
24. Migliori GB, Ong CWM, Petrone L, et al. The definition of tuberculosis infection based on the spectrum of tuberculosis disease. Breathe 2021; 17: 210079.
25. Min, J., Jeong, Y., Kim, H.W. and Kim, J.S., 2024. Tuberculosis notification and incidence: Republic of Korea, 2022. Tuberculosis and Respiratory Diseases, 87(3), p.411.
26. Miyoshi, S., Semba, M., Tanabe, M., Sato, C., Watanabe, A., Ito, R., Kubota, M. and Abe, M., 2025. Assessment of Risk Factors for Death in Older Adult Patients With TB in Japan. CHEST Pulmonary, 3(2).
27. Motta, I., Boeree, M., Chesov, D., Dheda, K., Günther, G., Horsburgh Jr, C.R., Kherabi, Y., Lange, C., Lienhardt, C., McIlleron, H.M. and Paton, N.I., 2024. Recent advances in the treatment of tuberculosis. Clinical Microbiology and Infection, 30(9), pp.1107-1114.
28. Mulaku, M.N., Ochodo, E., Young, T. and Steingart, K.R., 2024. Pre-treatment loss to follow-up in adults with pulmonary TB in Kenya. Public Health Action, 14(1), pp.34-39.
29. Munir, M.A., Khan, S., Rehman, S., Ahmed, D. and Jabbar, A., 2024. Tuberculosis among diabetes patients: a review of epidemiology, pathophysiology, clinical manifestations, and management. Chronicles of Biomedical Sciences, 1(3), pp.PID26-PID26.
30. Murray, M., Oxlade, O. and Lin, H.H., 2011. Modeling social, environmental and biological determinants of tuberculosis. The International Journal of Tuberculosis and Lung Disease, 15(6), pp.S64-S70.
31. Murrill, M.T., Salcedo, K., Tschampl, C.A., Ahamed, N., Coates, E.S., Flood, J., Wegener, D.H. and Shete, P.B., 2025. Policy Impediments to Tuberculosis Elimination: Consequences of an Absent Medicare National Coverage Determination for Tuberculosis Prevention. Journal of Immigrant and Minority Health, pp.1-6.

Referensi Tuberkulosis J-K

 See also: https://yosephsamodra.com

1. Jagger, P., McCord, R., Gallerani, A., Hoffman, I., Jumbe, C., Pedit, J., Phiri, S., Krysiak, R. and Maleta, K., 2024. Household air pollution exposure and risk of tuberculosis: a case–control study of women in Lilongwe, Malawi. BMJ Public Health, 2(1).
2. Jeong D, et al. Prevalence and associated factors of diabetes mellitus among patients with tuberculosis in South Korea from 2011 to 2018: a nationwide cohort study. BMJ Open 2023;13:e069642.
3. Jesus, G.S., Gestal, P.F., Silva, A.F., Cavalcanti, D.M., Lua, I., Ichihara, M.Y., Barreto, M.L., Boccia, D., Sanchez, M.N. and Rasella, D., 2025. Effects of conditional cash transfers on tuberculosis incidence and mortality according to race, ethnicity and socioeconomic factors in the 100 Million Brazilian Cohort. Nature Medicine, pp.1-10.
4. Jiang, Y., Zhang, W., Wei, M., Yin, D., Tang, Y., Jia, W., Wang, C., Guo, J., Li, A. and Gong, Y., 2024. Associations between type 1 diabetes and pulmonary tuberculosis: a bidirectional mendelian randomization study. Diabetology & Metabolic Syndrome, 16(1), pp.1-9.
5. Jiang, X., Feng, Y., Yu, Z., Chen, B., Wang, W., Jiang, G., Hu, L., Tong, W., Chen, Q., Zhang, M. and Zhu, Y., 2025. The latent tuberculosis infection survey using two interferon γ release assay tests among the elderly in a well-confined rural county in Eastern China. BMC geriatrics, 25(1), p.1035.
6. Jiang, F., Li, X., Qiao, Q., Zhang, M., Tian, Y., Zhou, S., Li, Y., Ni, R., Liu, Y., Zhang, L. and Gong, W., 2026. Global, regional, and national burden of tuberculosis, 1990–2050: a systematic comparative analysis based on retrospective cross-sectional of GBD 2021 and WHO surveillance systems. International Journal of Surgery, 112(1), pp.250-269.
7. Juliasih, N.N., Sakinah, L.F., Sari, R.M., Winarso, H., Siahaan, S.C.P. and Gunawan, E.J., 2024. Determinants of transmission prevention behavior among Tuberculosis patients in Surabaya, Indonesia. Infection Prevention in Practice, 6(4), p.100404.
8. Kamui, I. N. (2025). Determinants of tuberculosis medication adherence among TB patients at Kiambu Level Five Hospital, Kiambu County, Kenya. Journal of Medical and Health Sciences, 4(1), 1–15.
9. Kang, J.Y., Han, K., Lee, S.H. and Kim, M.K., 2023. Diabetes severity is strongly associated with the risk of active tuberculosis in people with type 2 diabetes: a nationwide cohort study with a 6-year follow-up. Respiratory Research, 24(1), pp.1-9.
10. Kang, Y.A., Kim, S.Y., Jo, K.W., Kim, H.J., Park, S.K., Kim, T.H., Kim, E.K., Lee, K.M., Lee, S.S., Park, J.S. and Koh, W.J., 2014. Impact of diabetes on treatment outcomes and long-term survival in multidrug-resistant tuberculosis. Respiration, 86(6), pp.472-478.
11. Karakousis, P.C. and Mooney, G., 2025. Respiratory isolation for tuberculosis: a historical perspective. The Journal of Infectious Diseases, 231(1), pp.3-9.
12. Kaur, R., Egli, T., Paynter, J., Murphy, R., Perumal, L., Lee, A., Harrison, A., Christmas, T., Lewis, C. and Nisbet, M., 2023. Tuberculosis and diabetes: increased hospitalisations and mortality associated with renal impairment. Internal Medicine Journal, 53(9), pp.1588-1594.
13. Khairunnisa C, Mardiati, Millizia A, Wahyuni S, Nabilah Lubis P, Ikhsan M. Risk Factors for Pulmonary Tuberculosis Transmission Among Prisoner in Correctional Facilities in Lhokseumawe City, Aceh, Indonesia. Natl J Community Med 2025;16(6):582-588.
14. Khalid N, Ahmad F, Qureshi FM. Association amid the comorbidity of Diabetes Mellitus in patients of Active Tuberculosis in Pakistan: A matched case control study. Pak J Med Sci. 2021;37(3):816-820.
15. Khan, P.Y., Paracha, M.S., Grundy, C., Madhani, F., Saeed, S., Maniar, L., Dojki, M., Page-Shipp, L., Khursheed, N., Rabbani, W. and Riaz, N., 2024. Insights into tuberculosis burden in Karachi, Pakistan: A concurrent adult tuberculosis prevalence and child Mycobacterium tuberculosis infection survey. PLOS global public health, 4(8), p.e0002155.
16. Khanna, A., Saha, R. and Ahmad, N., 2023. National TB elimination programme-what has changed. Indian Journal of Medical Microbiology, 42, pp.103-107.
17. Khattak M, et al. (2024). Tuberculosis (TB) treatment challenges in TB-diabetes comorbid patients: a systematic review and meta-analysis, Annals of Medicine, 56:1, 2313683.
18. Kibirige, D., Andia-Biraro, I., Olum, R., Adakun, S., Zawedde-Muyanja, S., Sekaggya-Wiltshire, C. and Kimuli, I., 2024. Tuberculosis and diabetes mellitus comorbidity in an adult Ugandan population. BMC Infectious Diseases, 24(1), p.242.
19. Kibirige, D., Andia-Biraro, I., Kyazze, A.P., Olum, R., Bongomin, F., Nakavuma, R.M., Ssekamatte, P., Emoru, R., Nalubega, G., Chamba, N. and Kilonzo, K., 2023. Burden and associated phenotypic characteristics of tuberculosis infection in adult Africans with diabetes: a systematic review. Scientific Reports, 13(1), p.19894.
20. Kim, S.H., Park, Y.M., Han, K., Ko, S.H., Kim, S.Y., Song, S.H., Kim, C.H., Hur, K.Y. and Kim, S.K., 2022. Association of weight change following smoking cessation with the risk of tuberculosis development: A nationwide population-based cohort study. Plos one, 17(4), p.e0266262.
21. Kim KH, Kim HW, Kim YH, Park Y, Jung SS, Kim JW, et al. Effect of complicated, untreated and uncontrolled diabetes and pre-diabetes on treatment outcome among patients with pulmonary tuberculosis. Respirology. 2024; 29(7): 624–632.
22. Kirimi, E.M., Muthuri, G.G., Ngari, C.G. and Karanja, S., 2024. A Model for the Propagation and Control of Pulmonary Tuberculosis Disease in Kenya. Discrete Dynamics in Nature and Society, 2024(1), p.5883142.
23. Ko, T.H., Chang, Y.C., Chang, C.H., Liao, K.C.W., Magee, M.J. and Lin, H.H., 2023. Prediabetes and risk of active tuberculosis: a cohort study from Northern Taiwan. International Journal of Epidemiology, 52(3), pp.932-941.
24. Kobayashi, S., Yoshiyama, T., Uchimura, K., Hamaguchi, Y. and Kato, S., 2021. Epidemiology of childhood tuberculosis after ceasing universal Bacillus Calmette–Guérin vaccination. Scientific Reports, 11(1), p.15902.
25. Kornfeld, H., Procter-Gray, E., Kumpatla, S., Kane, K., Li, W., Magee, M.J., Babu, S. and Viswanathan, V., 2023. Longitudinal trends in glycated hemoglobin during and after tuberculosis treatment. Diabetes Research and Clinical Practice, 196, p.110242.
26. Krishnamoorthy, Y., Nagarajan, R., Rajaa, S., Majella, M.G., Murali, S. and Jayaseelan, V., 2021. Progress of South East Asian Region countries towards achieving interim End TB Strategy targets for TB incidence and mortality: a modelling study. Public Health, 198, pp.9-16.
27. Kulmirzayeva, D., Prabakaran, I. and Javaid, M., 2025. Retrospective analysis of tuberculosis incidence in Kazakhstan for 2000-2023. Journal of Health Development, 60(1), pp.17-23.
28. Kumar, N.P., & Babu, S. (2023). Impact of diabetes mellitus on immunity to latent tuberculosis infection. Frontiers in Clinical Diabetes and Healthcare, 4, 1095467.
29. Kusmiyani, O.T., Hermanto, H. and Rosela, K., 2024. Analisis faktor yang berhubungan dengan kepatuhan minum obat anti tuberkulosis pada pasien TB paru di Puskesmas Samuda dan Bapinang Kotawaringin Timur. Jurnal Surya Medika, 10(1), pp.139-151.
30. Kwak SH, Jeong D, Mok J, Jeon D, Kang H-Y, Kim HJ, et al. (2023) Association between diabetes mellitus and cause of death in patients with tuberculosis: A Korean nationwide cohort study. PLoS ONE 18(12): e0295556.
31. Kyaw, W.M., Tay, J.Y., Lim, L.K.Y. and Ng, D.H.L., 2025. Time interval for QuantiFERON-TB Gold Plus conversion after last exposure with tuberculosis. ERJ Open Research, 11(3).

Referensi Tuberkulosis R-S

1. Rahmawati, Y., Jamil, I.R., Hidayah, I., Kusumawardani, D. and Wibowo, W., 2026. Spatial Econometric Analysis of the Impact of Health Infrastructure on TBC Patients Study Case in Indonesia Provinces Level. International Review for Spatial Planning and Sustainable Development, 14(1), pp.96-117.
2. Rajamanickam, A., Kothandaraman, S. P., Kumar, N. P., Viswanathan, V., Shanmugam, S., Hissar, S., Nott, S., Kornfeld, H., & Babu, S. (2024). Cytokine and chemokine profiles in pulmonary tuberculosis with pre-diabetes. Frontiers in Immunology, 15, 1447161.
3. Rakotomanana, F., Dreyfus, A., Randrianarisoa, M.M., Raberahona, M., Chevallier, E., Andriamasy, H.E., Bernardson, B.A., Ranaivomanana, P., Ralaitsilanihasy, F., Rasoamaharo, M. and Randrianirisoa, S.A., 2024. Prevalence of pulmonary tuberculosis and HIV infections and risk factors associated to tuberculosis in detained persons in Antananarivo, Madagascar. Scientific Reports, 14(1), p.8640.
4. Rani, A.Y.A., Ismail, N., Zakaria, Y. and Isa, M.R., 2024. A scoping review on socioeconomic factors affecting tuberculosis loss to follow-up in Southeast Asia. Med J Malaysia, 79(4), pp.470-476.
5. Rehman Au, Khattak M, Mushtaq U, Latif M, Ahmad I, Rasool MF, Shakeel S, Hayat K, Hussain R, Alhazmi GA, Alshomrani AO, Alalawi MI, Alghamdi S, Imam MT, Almarzoky Abuhussain SS, Khayyat SM and Haseeb A (2023) The impact of diabetes mellitus on the emergence of multi-drug resistant tuberculosis and treatment failure in TB-diabetes comorbid patients: a systematic review and meta-analysis. Front. Public Health 11:1244450.
6. Reid, M., Agbassi, Y.J.P., Arinaminpathy, N., Bercasio, A., Bhargava, A., Bhargava, M., Bloom, A., Cattamanchi, A., Chaisson, R., Chin, D. and Churchyard, G., 2023. Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis. The Lancet, 402(10411), pp.1473-1498.
7. Reta, M.A., Asmare, Z., Sisay, A., Gashaw, Y., Getachew, E., Gashaw, M., Dejazmach, Z., Jemal, A., Gedfie, S., Kumie, G. and Nigatie, M., 2024. Prevalence of pulmonary tuberculosis among key and vulnerable populations in hotspot settings of Ethiopia. A systematic review and meta-analysis. Plos one, 19(8), p.e0309445.
8. Ridwan, I., Sofiah, F. and Rismarini, R., 2025. Rate of administration of tuberculosis preventive treatment to pediatric household contacts and influencing factors. Paediatrica Indonesiana, 65(5):422-430.
9. Rima, U.S., Islam, J., Mim, S.I., Roy, A., Dutta, T., Dutta, B. and Ferdaus, F.F., 2024. Co-Infection of Tuberculosis and Diabetes: Implications for Treatment and Management. Asia Pacific Journal of Surgical Advances, 1(2), pp.51-58.
10. Rochmah, A.F., Zahroh, C., Nadatien, I., Setiyowati, E., & Hidaayah, N. (2024). Does education influence self-efficacy in tuberculosis patients? A systematic review. Journal of Applied Nursing and Health, 6(1), 128–138.
11. Saisudjarit, P., Saokaew, S., Duangjai, A., Prasatkhetragarn, A., Kanchanasurakit, S. and Phisalprapa, P., 2026. External Validation of a Simple Mortality Risk Prediction Score for Tuberculosis Patients. Journal of Health Research, 40(1), p.3.
12. Salindri AD, Auld SC, Gujral UP, et al. Tuberculosis Infection and Hypertension: Prevalence Estimates from the US National Health and Nutrition Examination Survey. BMJ Open. 2024;14:e075176.
13. Salindri, A.D., Haw, J.S., Amere, G.A., Alese, J.T., Umpierrez, G.E. and Magee, M.J., 2021. Latent tuberculosis infection among patients with and without type-2 diabetes mellitus: results from a hospital case-control study in Atlanta. BMC Research Notes, 14(1), p.252.
14. Salindri, A.D., Wang, J.Y., Lin, H.H. and Magee, M.J., 2019. Post-tuberculosis incidence of diabetes, myocardial infarction, and stroke: retrospective cohort analysis of patients formerly treated for tuberculosis in Taiwan, 2002–2013. International Journal of Infectious Diseases, 84, pp.127-130.
15. Sanchini, A., Lanni, A., Giannoni, F. and Mustazzolu, A., 2024. Exploring Diagnostic Methods for Drug-Resistant Tuberculosis: A Comprehensive Overview. Tuberculosis, p.102522.
16. Sani, H.A., Hadi, A.J. and Hatta, H., 2025. Key Determinants of Tuberculosis Prevention Behaviors Among Families in Indonesia: A Cross-Sectional Study Analysis. Media Publikasi Promosi Kesehatan Indonesia (MPPKI), 8(2), pp.118-130.
17. Saunders, M.J., Montoya, R., Quevedo, L., Ramos, E., Datta, S. and Evans, C.A., 2025. The social determinants of tuberculosis: a case-control study characterising pathways to equitable intervention in Peru. Infectious diseases of poverty, 14(1), p.53.
18. Segura-Cerda, C.A., López-Romero, W. and Flores-Valdez, M.A., 2019. Changes in host response to mycobacterium tuberculosis infection associated with type 2 diabetes: beyond hyperglycemia. Frontiers in cellular and infection microbiology, 9, p.342.
19. Septa, D. and Surjadi, L.M., 2023. Glycemic Control Effect on Acid-Fast Bacteria Conversion in Diabetic Patients with Tuberculosis. Jurnal Biomedika dan Kesehatan, 6(1), pp.62-70.
20. Shabil, M., Bushi, G., Beig, M.A., Rais, M.A., Ahmed, M. and Padhi, B.K., 2023. Cardiovascular manifestation in tuberculosis cases: a systematic review and meta-analysis. Current Problems in Cardiology, 48(7), p.101666.
21. Shaluhiyah, Z., Handayani, S., Sriatmi, A., Agushybana, F. and Rimawati, E., 2025. Understanding tuberculosis as a wicked problem: a qualitative study in coastal urban settlements of Semarang, Indonesia. Frontiers in Communication, 10, p.1719819.
22. Shanmuham, V., Shetty, J.K. and Naik, V.R., 2022. Incidence of tuberculosis in the association of South-East Asia Nation (ASEAN) countries and its relation with health expenditure: a secondary data analysis. Manipal Journal of Nursing and Health Sciences, 8(1), p.7.
23. Shete, P.B., Kadota, J.L., Nanyunja, G., Namale, C., Nalugwa, T., Oyuku, D., Turyahabwe, S., Kiwanuka, N., Cattamanchi, A. and Katamba, A., 2023. Evaluating the impact of cash transfers on tuberculosis (ExaCT TB): a stepped wedge cluster randomised controlled trial. ERJ open research, 9(3).
24. Shewade, H.D., Ravichandran, P., Pradeep, S.K., Kiruthika, G., Shanmugasundaram, D., Chadwick, J., Iyer, S., Chowdhury, A., Tumu, D., Shah, A.N. and Vadera, B., 2024. Bridging the “know-do” gap to improve active case finding for tuberculosis in India: A qualitative exploration into national tuberculosis elimination program staffs’ perspectives. PloS one, 19(11), p.e0309750.
25. Shi H, Yuan Y, Li X, Li YF, Fan L, Yang XM. Analysis of the influencing factors and clinical related characteristics of pulmonary tuberculosis in patients with type 2 diabetes mellitus. World J Diabetes 2024; 15(2): 196-208.
26. Shu, C.C., Hsu, C.L., Wei, Y.F., Lee, C.Y., Liou, H.H., Wu, V.C., Yang, F.J., Lin, H.H., Wang, J.Y., Chen, J.S. and Yu, C.J., 2016. Risk of tuberculosis among patients on dialysis: the predictive value of serial interferon-gamma release assay. Medicine, 95(22), p.e3813.
27. Shu, CC., Wei, YF., Yeh, YC. et al. The impact on incident tuberculosis by kidney function impairment status: analysis of severity relationship. Respir Res 21, 51 (2020).
28. Silva, M.T. and Galvão, T.F., 2024. Tuberculosis incidence in Brazil: time series analysis between 2001 and 2021 and projection until 2030. Revista Brasileira de Epidemiologia, 27, p.e240027.
29. Smith, A. G. C., Kempker, R. R., Wassie, L., Bobosha, K., Nizam, A., Gandhi, N. R., Auld, S. C., Magee, M. J., Blumberg, H. M., & Tuberculosis Research Unit: Role of Antigen Specific Responses in the Control of TB (TBRU-ASTRa) Study Group. (2022). The impact of diabetes and prediabetes on prevalence of Mycobacterium tuberculosis infection among household contacts of active tuberculosis cases in Ethiopia. Open Forum Infectious Diseases, 9(7), ofac323.
30. Soemarko, D.S., Halim, F.A., Kekalih, A., Yunus, F., Werdhani, R.A., Sugiharto, A., Mansyur, M., Wingfield, T. and Fuady, A., 2023. Developing a tool to measure tuberculosis-related stigma in workplaces in Indonesia: An internal validation study. SSM-Population Health, 21, p.101337.
31. Soeroto, A.Y., Pratiwi, C., Santoso, P. and Lestari, B.W., 2021. Factors affecting outcome of longer regimen multidrug-resistant tuberculosis treatment in West Java Indonesia: A retrospective cohort study. PloS one, 16(2), p.e0246284.
32. Sofiana, L., Muthiah, T.A.S. and Putri, N. (2024) Analysis of directly observed treatment shortcourse implementation as an effort to control tuberculosis in Yogyakarta. The Indonesian Journal of Public Health, 19(3), pp. 507–519.
33. Solanki HM, Ranpariya PN, Chudasama RK. Health status and treatment outcome of tuberculosis with diabetes mellitus cases, Rajkot City, Gujarat – A longitudinal study. Indian J Community Med 2023;48:75‑81.
34. Song, W.M., Guo, J., Xu, T.T., Li, S.J., Liu, J.Y., Tao, N.N., Liu, Y., Zhang, Q.Y., Liu, S.Q., An, Q.Q. and Li, Y.F., 2021. Association between body mass index and newly diagnosed drug-resistant pulmonary tuberculosis in Shandong, China from 2004 to 2019. BMC pulmonary medicine, 21, pp.1-14.
35. Sopiani, P., Maemun, S., Azijah, I., Pratiwi, T.Z. and Saputra, R., 2025. Analysis of Risk Factors for Pulmonary Tuberculosis in Cirascas District, East Jakarta, 2022. The Indonesian Journal of Infectious Diseases, 11(1), pp.42-51.
36. Sorokina, M., Ukubayev, T. and Koichubekov, B., 2023. Tuberculosis incidence and its socioeconomic determinants: developing a parsimonious model. Annali di Igiene, Medicina Preventiva e di Comunita, 35(4): 468-479.
37. Ssekamatte P, Sande OJ, van Crevel R and Biraro IA (2023). Immunologic, metabolic and genetic impact of diabetes on tuberculosis susceptibility. Front. Immunol. 14:1122255.
38. Ssentongo, S.M., Oryokot, B., Opito, R., Ochieng, G., Sekiranda, P., Bakashaba, B. and Mugisha, K., 2025. Treatment success and associated factors among drug-susceptible tuberculosis patients in Teso region, Uganda: a retrospective study. Therapeutic Advances in Infectious Disease, 12, pp.1-12.
39. Soedarsono, S., Mertaniasih, N.M., Kusmiati, T., Permatasari, A., Subay, S. and Adiono, S.H., 2024. Comparison of Individual Regimen Containing Bedaquiline with Delamanid and Bedaquiline without Delamanid on Efficacy and Safety in Multidrug-resistant Tuberculosis Patients: Implementation in Dr. Soetomo General Academic Hospital, Indonesia. The International Journal of Mycobacteriology, 13(2), pp.140-146.
40. Sun H-Y, Wang J-Y, Chen Y-C, Hsueh PR, Chen Y-H, Chuang Y-C, et al. (2020) Impact of introducing fluorescent microscopy on hospital tuberculosis control: A before-after study at a high caseload medical center in Taiwan. PLoS ONE 15(4): e0230067.
41. Suprijandani, S., Setiawan, S., Pathurrahman, P., Wardoyo, S. and Rahayyu, A.M., 2025. The behaviour of TB patients in East Lombok through a health belief model approach. Journal of Health, Population and Nutrition, 44(1), p.23.
42. Susilawati, T.N. and Larasati, R., 2019. A recent update of the diagnostic methods for tuberculosis and their applicability in Indonesia: a narrative review. Medical Journal of Indonesia, 28(3), pp.284-91.
43. Suwannacho, R., Anantachina, N. and Sornprom, C., 2024. Glycated hemoglobin level and sputum acid—fast bacilli conversion in pulmonary tuberculosis. The Clinical Academia, 48(3), pp.84-91.
44. Swartwood, N.A., Li, Y., Regan, M., Marks, S.M., Barham, T., Asay, G.R.B., Cohen, T., Hill, A.N., Horsburgh, C.R., Khan, A.D. and McCree, D.H., 2024. Estimated Health and Economic Outcomes of Racial and Ethnic Tuberculosis Disparities in US-Born Persons. JAMA Network Open, 7(9), pp.e2431988-e2431988.
45. Syafiq, N.J.M., Trivedi, A.A., Lai, A., Fontelera, M.P.A. and Lim, M.A., 2023. Latent tuberculosis infection in health-care workers in the government sector in Brunei Darussalam: A cross-sectional study. Journal of Integrative Nursing, 5(3), pp.197-202.
46. Syahrani, F., Lestari, H. and Irma, I., 2025. Faktor Risiko Kejadian TBC pada Usia Produktif di Puskesmas Poasia, Kota Kendari Tahun 2024. Jurnal Kendari Kesehatan Masyarakat, 4(3), pp.221-229.
47. Syukur, A., Yulia, Y. and Istikomah, N.R., 2024. Hubungan Kondisi Lingkungan Rumah Dengan Kejadian Tb. Paru Pada Anak Di Kabupaten Sambas. Journal of Innovation Research and Knowledge, 4(6), pp.3795-3806.

Referensi Tuberkulosis G-I

1. Galán, M.D.M.D., Redondo-Bravo, L., Gómez-Barroso, D., Herrera, L., Amillategui, R., Gómez-Castellá, J. and Herrador, Z., 2024. The impact of meteorological factors on tuberculosis incidence in Spain: a spatiotemporal analysis. Epidemiology & Infection, 152, p.e58.
2. Galib, R.K., Paul, S.K., Akter, K., Musa, M.I., Sarker, D.J., Choudhury, S.A.R.A., Paul, S.C. and Chakrabortty, R., 2025. Frequency of Lower Lung Field Tuberculosis in Diabetes Mellitus Patients Attending Tertiary Care Hospital in Bangladesh: A Cross‐Sectional Study. Health Science Reports, 8(1), p.e70413.
3. Gebreweld, A., Fiseha, T., Kebede, E., Tamir, Z., Gebremariam, B., Miruts, F. and Haileslasie, H., 2024. Immuno-Hematological and Biochemical Changes in Patients with Tuberculosis in Dessie Comprehensive Specialized Hospital, Dessie, Ethiopia. Journal of Blood Medicine, pp.147-155.
4. Giridharan, P., Suseela, R.P., Zangpo, T., Joshi, R.B., Cader, M., Isbaniah, F., Velayudham, B., Rafeeg, F.N., da Cruz Santos, A., Shah, N.P. and Mathew, M., 2024. Tuberculosis preventive treatment in eight SEAR countries–Current practices, implementation challenges and operations research priorities. Public Health in Practice, 8, p.100518.
5. Godoy, S., Parrón, I., Millet, J.P., Caylà, J.A., Follia, N., Carol, M., Orcau, A., Alsedà, M., Toledo, D., Plans, P. and Ferrús, G., 2024. Risk of tuberculosis among pulmonary tuberculosis contacts: the importance of time of exposure to index cases. Annals of Epidemiology, 91, pp.12-17.
6. Goletti, D., Pisapia, R., Fusco, F.M., Aiello, A. and Van Crevel, R., 2023. Epidemiology, pathogenesis, clinical presentation and management of TB in patients with HIV and diabetes. The International Journal of Tuberculosis and Lung Disease, 27(4), pp.284-290.
7. Guillén, S.M., et al., 2023. Tuberculosis in Spain: An opinion paper. Rev Esp Quimioter, 36(6), pp.562-583.
8. Gupta-Wright, Ankur, Huy Ha, Shima Abdulgadar, Rebecca Crowder, Jerusha Emmanuel, Job Mukwatamundu, Danaida Marcelo et al. "Evaluation of the Xpert MTB Host Response assay for the triage of patients with presumed pulmonary tuberculosis: a prospective diagnostic accuracy study in Viet Nam, India, the Philippines, Uganda, and South Africa." The Lancet Global Health 12, no. 2 (2024): e226-e234.
9. Gurumurthy, M., Gopalan, N., Patel, L., Davis, A., Srinivasalu, V.A., Rajaram, S., Goodall, R., Bronson, G. and STREAM Trial Collaboration, 2025. Treatment outcomes in people with diabetes and multidrug-resistant tuberculosis (MDR TB) enrolled in the STREAM clinical trial. PLOS Global Public Health, 5(4), p.e0004259.
10. Habib, M.A., Afrin, K., Efa, S.S., Hossain, M.D., Islam, M.R., Rahman, M.M., Islam, N., Afroz, F., Rahim, M.A. and Hossain, M.D., 2024. Effects of diabetes mellitus on retreatment of Tuberculosis: A multi-centered case-control study from Bangladesh. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 36, p.100450.
11. Hakam, M.A., Safitri, B.D., Wandastuti, A.D., Husni, M.F., Setiawan, A.W., Konoralma, A.R., Radja, B.L., Setiono, O. and Wulan, W.R., 2024. The Relationship Between Adequate Housing And Household Sanitation With The Success Of Tuberculosis Patient Treatment In Semarang City. International Journal of Health Literacy and Science, 2(2), pp.14-19.
12. Hamada, Y., Quartagno, M., Law, I., Malik, F., Bonsu, F.A., Adetifa, I.M., Adusi-Poku, Y., D'Alessandro, U., Bashorun, A.O., Begum, V. and Lolong, D.B., 2023. Association of diabetes, smoking, and alcohol use with subclinical-to-symptomatic spectrum of tuberculosis in 16 countries: an individual participant data meta-analysis of national tuberculosis prevalence surveys. EClinicalMedicine, 63.
13. Hamada, Y., Lugendo, A., Ntshiqa, T., Kubeka, G., Lalashowi, J.M., Mwastaula, S., Ntshamane, K., Sabi, I., Wilson, S., Copas, A. and Velen, K., 2024. A pilot cross-sectional study of non-communicable diseases in TB household contacts. IJTLD OPEN, 1(4), pp.154-159.
14. Handayani, S. and Isworo, S., 2024. Evaluation of Tuberculosis program implementation in Primary Health Care, Semarang, Indonesia. International Journal of Public Health Asia Pacific, pp.1-11.
15. Handayani, L., 2024. Studi Epidemiologi Tuberkulosis Paru (TB) di Indonesia: Temuan Survey Kesehatan Indonesia (SKI) 2023. Jurnal Kendari Kesehatan Masyarakat, 4(1), pp.59-67.
16. Harahap, E.C.L., Purwanti, A. and Hardianto, N., 2024. Perbedaan Proporsi Sputum Bakteri Tahan Asam Positif pada Pasien Diabetes Melitus Terkendali dan Tidak Terkendali. Jurnal Laboratorium Khatulistiwa, 8(1), pp.168-180.
17. Hariyanto, S.W., Avidati, H., Ulfah, U., Nurlaily, A.N. and Tejaningrum, K.D., Tuberculosis Screening in Patients with Diabetes Mellitus at the Internal Medicine Clinic of UGM Academic Hospital: Descriptive Study. Academic Hospital Journal, 7(1), p.8.
18. Herman, D., Machmud, R. and Lipoeto, N.I., 2025. Unraveling the Link between Obesity and Tuberculosis: A Systematic Review of the Underlying Mechanisms. Bioscientia Medicina: Journal of Biomedicine and Translational Research, 9(2), pp.6453-6466.
19. Hong, K.J., Wang, T.C. and Tsui, K., 2025. Association of acid-suppressive therapy and tuberculosis: A causal or coincidental link to the infection?. Respiratory Investigation, 63(1), pp.27-32.
20. Houben, R.M., Menzies, N.A., Sumner, T., Huynh, G.H., Arinaminpathy, N., Goldhaber-Fiebert, J.D., Lin, H.H., Wu, C.Y., Mandal, S., Pandey, S. and Suen, S.C., 2016. Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models. The Lancet Global Health, 4(11), pp.e806-e815.
21. Hsu, C.M., Wu, C.J., Chang, C.J., Pan, S.W., Tseng, Y.H., Huang, J.R., Su, W.J., Feng, J.Y. and Chen, Y.M., 2025. Recurrence of tuberculosis and associated risk factors among Non-HIV patients in Taiwan: A retrospective cohort study. Journal of Infection and Public Health, p.102912.
22. Huang, F. and Bello, S.T., 2024. Spatiotemporal analysis of regional and age differences in tuberculosis prevalence in mainland China. Tropical Medicine & International Health, 29(9), pp.833-841.
23. Huang, H.L., Cheng, M.H., Lee, M.R., Chien, J.Y., Lu, P.L., Sheu, C.C., Wang, J.Y., Chong, I.W., Yang, J.M. and Huang, W.C., 2025. Prevalence and treatment outcomes of latent tuberculosis infection among older patients with chronic obstructive pulmonary disease in an area with intermediate tuberculosis burden. Emerging Microbes & Infections, 14(1), p.2497302.
24. Huang, H.L., Huang, W.C., Lin, K.D., Liu, S.S., Lee, M.R., Cheng, M.H., Chin, C.S., Lu, P.L., Sheu, C.C., Wang, J.Y. and Lee, I.T., 2021. Completion rate and safety of programmatic screening and treatment for latent tuberculosis infection in elderly patients with poorly controlled diabetic mellitus: a prospective multicenter study. Clinical Infectious Diseases, 73(6), pp.e1252-e1260.
25. Huang, Y.W., Yu, M.C., Lin, C.B., Lee, J.J., Lin, C.J., Chien, S.T., Lee, C.H. and Chiang, C.Y., 2024. Mitigating treatment failure of pulmonary pre-extensively drug-resistant tuberculosis: The role of new and repurposed drugs. Journal of Microbiology, Immunology and Infection, 57(4), pp.617-628.
26. Hung, L.C., Kung, P.T., Tsai, T.H., Tsai, W.C. and Huang, K.H., 2025. Risk Assessment of Tuberculosis in Patients With Chronic Mental Illness and Related Factors: A Population‐Based Cohort Study in Taiwan. The Clinical Respiratory Journal, 19(6), p.e70088.
27. Innes, A.L., Lebrun, V., Hoang, G.L., Martinez, A., Dinh, N., Nguyen, T.T.H., Huynh, T.P., Quach, V.L., Nguyen, T.B., Trieu, V.C. and Tran, N.D.B., 2024. An effective health system approach to end TB: implementing the double X strategy in Vietnam. Global Health: Science and Practice, 12(3).
28. Iskandar, D., Suwantika, A.A., Pradipta, I.S., Postma, M.J. and van Boven, J.F., 2023. Clinical and economic burden of drug-susceptible tuberculosis in Indonesia: national trends 2017–19. The Lancet Global Health, 11(1), pp.e117-e125.
29. Ismail, Nazir, Harry Moultrie, Judith Mwansa-Kambafwile, Andrew Copas, Alane Izu, Sizulu Moyo, Donald Skinner et al. "Effects of conditional cash transfers and pre-test and post-test tuberculosis counselling on patient outcomes and loss to follow-up across the continuum of care in South Africa: a randomised controlled trial." The Lancet Infectious Diseases (2025).

 

Referensi Tuberkulosis D-F

 

1. d'Elbée, M., Harker, M., Mafirakureva, N., Nanfuka, M., Nguyet, M.H.T.N., Taguebue, J.V., Moh, R., Khosa, C., Mustapha, A., Mwanga-Amumpere, J. and Borand, L., 2024. Cost-effectiveness and budget impact of decentralising childhood tuberculosis diagnosis in six high tuberculosis incidence countries: a mathematical modelling study. EClinicalMedicine, 70, p.102528.
2. Dalimunthe, A., Sinaga, B.Y.M., Siagian, P. and Amelia, R., 2025. Social Support and Healthcare Service Quality as Determinants of Treatment Interruption Among Drug-Resistant Tuberculosis Patients in Medan, Indonesia. Jurnal Impresi Indonesia, 4(11), pp.5176-5183.
3. Dasan, B., Rajamanickam, A., Pandiarajan, A.N., Shanmugam, S., Nott, S. and Babu, S., 2025. Immunological mechanisms of tuberculosis susceptibility in TB-infected individuals with type 2 diabetes mellitus: insights from mycobacterial growth inhibition assay and cytokine analysis. Microbiology Spectrum, 13(1), pp.e01445-24.
4. Dewi, N.P.A.N. and Susilawati, N.M., 2024. Hubungan Pekerjaan dan Pendidikan dengan Kejadian TB Paru di Kota Kupang. Inovasi Kesehatan Global, 1(4), pp.139-148.
5. Dodd, P.J., Yuen, C.M., Jayasooriya, S.M., van der Zalm, M.M. and Seddon, J.A., 2021. Quantifying the global number of tuberculosis survivors: a modelling study. The Lancet Infectious Diseases, 21(7), pp.984-992.
6. Dos Santos, P.C.P., Messina, N.L., de Oliveira, R.D., da Silva, P.V., Puga, M.A.M., Dalcolmo, M., Dos Santos, G., de Lacerda, M.V.G., Jardim, B.A., e Val, F.F.D.A. and Curtis, N., 2024. Effect of BCG vaccination against Mycobacterium tuberculosis infection in adult Brazilian health-care workers: a nested clinical trial. The Lancet Infectious Diseases, 24(6), pp.594-601.
7. Du, Z.X., Ren, Y.Y., Wang, J.L., Li, S.X., Hu, Y.F., Wang, L., Chen, M.Y., Li, Y., Hu, C.M. and Yang, Y.F., 2024. The potential association between metabolic disorders and pulmonary tuberculosis: a Mendelian randomization study. European Journal of Medical Research, 29(1), p.277.
8. Dye, C., Garnett, G.P., Sleeman, K. and Williams, B.G., 1998. Prospects for worldwide tuberculosis control under the WHO DOTS strategy. The Lancet, 352(9144), pp.1886-1891.
9. Dye, C., Watt, C.J., Bleed, D.M., Hosseini, S.M. and Raviglione, M.C., 2005. Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. Jama, 293(22), pp.2767-2775.
10. Eksa, D.R., Hendarto, G.S., Sinaga, F.T., Dilangga, P., Herdato, M.J.D., Infianto, A., Ekawati, D., Gozali, A. and Ajipurnomo, A., 2025. Comparative Diagnostic Accuracy of LF-LAM TB Antigen and Xpert MTB/RIF in Pulmonary Tuberculosis among Underweight Patients. Jurnal Respirologi Indonesia, 45(4), pp.272-279.
11. Eksombatchai, D., Jeong, D., Mok, J., Jeon, D., Kang, H.Y., Kim, H.J., Kim, H.S., Choi, H. and Kang, Y.A., 2023. Sex differences in the impact of diabetes mellitus on tuberculosis recurrence: a retrospective national cohort study. International Journal of Infectious Diseases, 127, pp.1-10.
12. Esmail, A., Randall, P., Oelofse, S. et al. Comparison of two diagnostic intervention packages for community-based active case finding for tuberculosis: an open-label randomized controlled trial. Nat Med 29, 1009–1016 (2023).
13. Evans, D., Hirasen, K., Casalme, D.J., Gler, M.T., Gupta, A. and Juneja, S., 2024. Cost and cost-effectiveness of BPaL regimen used in drug-resistant TB treatment in the Philippines. IJTLD open, 1(6), pp.242-249.
14. Fadhilah, A.N. and Wikandari, R.J., 2024. The relationship between the length of treatment for pulmonary tuberculosis patients in the intensive phase and hemoglobin levels. Journal of Indonesian Medical Laboratory and Science, 5(2), pp.140-149.
15. Fahdhienie, F., Mudatsir, M., Abidin, T.F. and Nurjannah, N., 2024. Risk factors of pulmonary tuberculosis in Indonesia: a case-control study in a high disease prevalence region. Narra J, 4(2), p.e943.
16. Fitri, V.K., Zaman, C., Priyanto, A.D. and Ekawati, D., 2025. Analysis Factor of Compliance With Taking Anti-Pulmonary Tuberculosis Drugs in Patients With Pulmonary Tuberculosis. Lentera Perawat, 6(1), pp.59-68.
17. Foster, N., Cunnama, L., McCarthy, K., Ramma, L., Siapka, M., Sinanovic, E., Churchyard, G., Fielding, K., Grant, A.D. and Cleary, S., 2021. Strengthening health systems to improve the value of tuberculosis diagnostics in South Africa: A cost and cost-effectiveness analysis. Plos one, 16(5), p.e0251547.
18. Franco, J.V., Bongaerts, B., Metzendorf, M.I., Risso, A., Guo, Y., Silva, L.P., Boeckmann, M., Schlesinger, S., Damen, J.A., Richter, B. and Baddeley, A., 2024. Diabetes as a risk factor for tuberculosis disease. The Cochrane database of systematic reviews, 8, p.CD016013.
19. Franke, M.A., Emmrich, J.V., Ranjaharinony, F., Ravololohanitra, O.G., Andriamasy, H.E., Knauss, S. and Muller, N., 2024. A cross-sectional analysis of the effectiveness of a nutritional support programme for people with tuberculosis in Southern Madagascar using secondary data from a non-governmental organisation. Infectious Diseases of Poverty, 13(1), p.13.
20. Fu, H., Lin, H.H., Hallett, T.B. and Arinaminpathy, N., 2018. Modelling the effect of discontinuing universal Bacillus Calmette-Guérin vaccination in an intermediate tuberculosis burden setting. Vaccine, 36(39), pp.5902-5909.
21. Fu, H., Lin, HH., Hallett, T.B. et al. Explaining age disparities in tuberculosis burden in Taiwan: a modelling study. BMC Infect Dis 20, 191 (2020). https://doi.org/10.1186/s12879-020-4914-2
22. Fuady, A., Hutanamon, T., Herlinda, O., Luntungan, N. and Wingfield, T., 2024. Achieving universal social protection for people with tuberculosis. The Lancet Public Health, 9(5), pp.e339-e344.
23. Furin, J., Cox, H., & Pai, M. (2019). Tuberculosis. Lancet (London, England), 393(10181), 1642–1656.

Referensi Tuberkulosis L

1. Lai, T.C., Chiang, C.Y., Wu, C.F., Yang, S.L., Liu, D.P., Chan, C.C. and Lin, H.H., 2016. Ambient air pollution and risk of tuberculosis: a cohort study. Occupational and environmental medicine, 73(1), pp.56-61.
2. Langley, I., Doulla, B., Lin, H.H., Millington, K. and Squire, B., 2012. Modelling the impacts of new diagnostic tools for tuberculosis in developing countries to enhance policy decisions. Health care management science, 15, pp.239-253.
3. Langley, I., Lin, H.H., Egwaga, S., Doulla, B., Ku, C.C., Murray, M., Cohen, T. and Squire, S.B., 2014. Assessment of the patient, health system, and population effects of Xpert MTB/RIF and alternative diagnostics for tuberculosis in Tanzania: an integrated modelling approach. The Lancet Global Health, 2(10), pp.e581-e591.
4. Lee C-H, Lee M-C, Lin H-H, Shu C-C, Wang J-Y, et al. (2012) Pulmonary Tuberculosis and Delay in Anti-Tuberculous Treatment Are Important Risk Factors for Chronic Obstructive Pulmonary Disease. PLoS ONE 7(5): e37978.
5. Lee, P.H., Lin, H.C., Huang, A.S.E., Wei, S.H., Lai, M.S. and Lin, H.H., 2014. Diabetes and risk of tuberculosis relapse: nationwide nested case-control study. PloS one, 9(3), p.e92623.
6. Lee P-H, Fu H, Lai T-C, Chiang C-Y, Chan C-C, Lin H-H (2016) Glycemic Control and the Risk of Tuberculosis: A Cohort Study. PLoS Med 13(8): e1002072.
7. Lee, E.H., Lee, J.M., Kang, Y.A., Leem, A.Y., Kim, E.Y., Jung, J.Y., Park, M.S., Kim, Y.S., Kim, S.K., Chang, J. and Kim, S.Y., 2017. Prevalence and impact of diabetes mellitus among patients with active pulmonary tuberculosis in South Korea. Lung, 195, pp.209-215.
8. Lee, M.R., Huang, Y.P., Kuo, Y.T., Luo, C.H., Shih, Y.J., Shu, C.C., Wang, J.Y., Ko, J.C., Yu, C.J. and Lin, H.H., 2017. Diabetes mellitus and latent tuberculosis infection: a systemic review and metaanalysis. Clinical Infectious Diseases, 64(6), pp.719-727.
9. Lee, P.H., Fu, H., Lee, M.R., Magee, M. and Lin, H.H., 2018. Tuberculosis and diabetes in low and moderate tuberculosis incidence countries. The International Journal of Tuberculosis and Lung Disease, 22(1), pp.7-16.
10. Lee, M.R., Keng, L.T., Lee, M.C., Chen, J.H., Lee, C.H. and Wang, J.Y., 2024. Impact of isoniazid monoresistance on overall and vulnerable patient populations in Taiwan. Emerging Microbes & Infections, 13(1), p.2417855.
11. Lee, C.S., Ho, C.H., Liao, K.M., Wu, Y.C. and Shu, C.C., 2025. The impacts of SGLT2 inhibitors on the mortality of patients with tuberculosis. Journal of Infection and Public Health, p.102686.
12. Lestari, H., 2024. Analisis Epidemiologi Kejadian Tuberkulosis Di Provinsi Sulawesi Tenggara Tahun 2021-2023. Variable Research Journal, 1(02), pp.802-810.
13. Lestari, B.W., Nijman, G., Larasmanah, A., Soeroto, A.Y., Santoso, P., Alisjahbana, B., Chaidir, L., Andriyoko, B., Van Crevel, R. and Hill, P.C., 2024. Management of drug-resistant tuberculosis in Indonesia: a four-year cascade of care analysis. The Lancet Regional Health-Southeast Asia, 22:100294.
14. Li, H., Chee, C.B., Geng, T., Pan, A. and Koh, W.P., 2022. Joint associations of multiple lifestyle factors with risk of active tuberculosis in the population: the Singapore Chinese Health Study. Clinical Infectious Diseases, 75(2), pp.213-220.
15. Li, Z., Liu, Q., Chen, L., Zhou, L., Qi, W., Wang, C., Zhang, Y., Tao, B., Zhu, L., Martinez, L. and Lu, W., 2024. Ambient air pollution contributed to pulmonary tuberculosis in China. Emerging Microbes & Infections, 13(1), p.2399275.
16. Li, J., Zhao, Y., Jiang, Y., Zhang, Y., Zhang, P., Shen, L. and Chen, Z., 2024. Prevalence and risk factors of diabetes in patients with active pulmonary tuberculosis: a cross-sectional study in two financially affluent China cities. Diabetes, Metabolic Syndrome and Obesity, pp.1105-1114.
17. Liang, L. and Su, Q., 2024. Prediabetes and the treatment outcome of tuberculosis: A meta‐analysis. Tropical Medicine & International Health, 29(9), pp.757-767.
18. Lin, H.H., Murray, M., Cohen, T., Colijn, C. and Ezzati, M., 2008. Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study. The Lancet, 372(9648), pp.1473-1483.
19. Lin, H.H., Ezzati, M., Chang, H.Y. and Murray, M., 2009. Association between tobacco smoking and active tuberculosis in Taiwan: prospective cohort study. American journal of respiratory and critical care medicine, 180(5), pp.475-480.
20. Lin, H.H., Langley, I., Mwenda, R., Doulla, B., Egwaga, S., Millington, K.A., Mann, G.H., Murray, M., Squire, S.B. and Cohen, T., 2011. A modelling framework to support the selection and implementation of new tuberculosis diagnostic tools. The International journal of tuberculosis and lung disease, 15(8), pp.996-1004.
21. Lin, H., Shin, S., Blaya, J.A., Zhang, Z., Cegielski, P., Contreras, C., Asencios, L., Bonilla, C., Bayona, J., Paciorek, C.J. and Cohen, T., 2011. Assessing spatiotemporal patterns of multidrug-resistant and drug-sensitive tuberculosis in a South American setting. Epidemiology & Infection, 139(11), pp.1784-1793.
22. Lin, H.H., Dowdy, D., Dye, C., Murray, M. and Cohen, T., 2012. The impact of new tuberculosis diagnostics on transmission: why context matters. Bulletin of the World Health Organization, 90, pp.739-747.
23. Lin HH, Shin SS, Contreras C, Asencios L, Paciorek CJ, Cohen T. Use of spatial information to predict multidrug resistance in tuberculosis patients, Peru. Emerg Infect Dis. 2012 May;18(5):811-3. doi: 10.3201/eid1805.111467.
24. Lin, H.H., Chiang, Y.T., Chuang, J.H., Yang, S.L., Chang, H.Y., Ezzati, M. and Murray, M., 2013. Exposure to secondhand smoke and risk of tuberculosis: prospective cohort study. PloS one, 8(10), p.e77333.
25. Lin, H.H., Suk, C.W., Lo, H.L., Huang, R.Y., Enarson, D.A. and Chiang, C.Y., 2014. Indoor air pollution from solid fuel and tuberculosis: a systematic review and meta-analysis. The International journal of tuberculosis and lung disease, 18(5), pp.613-621.
26. Lin, H.H., Wang, L., Zhang, H., Ruan, Y., Chin, D.P. and Dye, C., 2015. Tuberculosis control in China: use of modelling to develop targets and policies. Bulletin of the World Health Organization, 93, pp.790-798.
27. Lin, H.H., Wu, C.Y., Wang, C.H., Fu, H., Lönnroth, K., Chang, Y.C. and Huang, Y.T., 2018. Association of obesity, diabetes, and risk of tuberculosis: two population-based cohorts. Clinical Infectious Diseases, 66(5), pp.699-705.
28. Lin, S.P., Chen, I.C., Lin, C.H., Hsiao, T.H., Liu, P.Y. and Chen, Y.M., 2025. Host Genetic Factors and Clinical Comorbidities Associated With Tuberculosis Risk. HLA, 106(3), p.e70384.
29. Liu, Q., You, N., Wen, J., Wang, J., Ge, Y., Shen, Y., Ding, X., Lu, P., Chen, C., Zhu, B. and Zhu, L., 2023. Yield and efficiency of a population-based mass tuberculosis screening intervention among persons with diabetes in Jiangsu Province, China. Clinical Infectious Diseases, 77(1), pp.103-111.
30. Liu, K.H., Xiao, Y.X. and Jou, R., 2024. Multidrug-resistant tuberculosis clusters and transmission in Taiwan: a population-based cohort study. Frontiers in Microbiology, 15, p.1439532.
31. Liu, C.Y., Chen, R.T., Shu, C.C. and Lin, S.Y., 2025. Prevalence, clinical reasons and associated factors of extended treatment duration for drug susceptible tuberculosis–a real-world experience. Scientific Reports, 15(1), pp.1-8.
32. Lo, H.Y., Yang, S.L., Lin, H.H., Bai, K.J., Lee, J.J., Lee, T.I. and Chiang, C.Y., 2016. Does enhanced diabetes management reduce the risk and improve the outcome of tuberculosis?. The International Journal of Tuberculosis and Lung Disease, 20(3), pp.376-382.
33. Lu, P., Zhang, Y., Liu, Q., Ding, X., Kong, W., Zhu, L. and Lu, W., 2021. Association of BMI, diabetes, and risk of tuberculosis: a population-based prospective cohort. International Journal of Infectious Diseases, 109, pp.168-173.
34. Lu, J.W., Mao, J.J., Zhang, R.R., Li, C.H., Sun, Y., Xu, W.Q., Zhuang, X., Zhang, B. and Qin, G., 2023. Association between long-term exposure to ambient air pollutants and the risk of tuberculosis: A time-series study in Nantong, China. Heliyon, 9(6).
35. Luo, D., Wang, F., Chen, S., Zhang, Y., Wang, W., Wu, Q., Ling, Y., Zhou, Y., Li, Y., Liu, K. and Chen, B., 2025. Application of the age-period-cohort model in tuberculosis. Frontiers in Public Health, 13, p.1486946.

Referensi Tuberkulosis Y-Z

1. Yamanaka, T., Castro, M.C., Ferrer, J.P., Solon, J.A., Cox, S.E., Laurence, Y.V. and Vassall, A., 2024. Health system costs of providing outpatient care for diabetes in people with TB in the Philippines. IJTLD open, 1(3), pp.124-129.
2. Yang, C.C., Shih, Y.J., Ayles, H., Godfrey-Faussett, P., Claassens, M. and Lin, H.H., 2024. Cost-effectiveness analysis of a prediction model for community-based screening of active tuberculosis. Journal of Global Health, 14, p.04226.
3. Yang, Y.J., Pan, S.C., Lee, M.R., Chung, C.L., Ku, C.P., Liao, C.Y., Tsai, T.Y., Wang, J.Y., Fang, C.T. and Chen, Y.C., 2024. Quantifying the contribution of smear-negative, culture-positive pulmonary tuberculosis to nosocomial transmission. American Journal of Infection Control, 52(7), pp.807-812.
4. Yang, B.R., Kang, Y.A., Heo, E.Y., Koo, B.K., Choi, N.K., Hwang, S.S. and Lee, C.H., 2018. Regional differences in the incidence of tuberculosis among patients with newly diagnosed diabetes mellitus. The Clinical Respiratory Journal, 12(4), pp.1732-1738.
5. Yanqiu X, Yang Y, Xiaoqing W, Zhixuan L, Kuan Z, Xin G, Bo Z, Jinyu W, Jing C, Yan M, Aiguo M. Impact of hyperglycemia on tuberculosis treatment outcomes: a cohort study. Scientific Reports. 2024 Jun 12;14(1):13586.
6. Ye, Z., Li, L., Yang, L., Zhuang, L., Aspatwar, A., Wang, L. and Gong, W., 2024. Impact of diabetes mellitus on tuberculosis prevention, diagnosis, and treatment from an immunologic perspective. In Exploration (p. 20230138).
7. Yeh, J.J., Chen, J.H., Kuo, Y.L., Tsai, C.H. and Ko, Y.E., 2025. A Clinical Prediction Model for Atypical Tuberculosis Manifestations Among Older Adults. Medicina, 61(10), p.1888.
8. Yoo JE, Kim D, Han K, Rhee SY, Shin DW, Lee H. Diabetes status and association with risk of tuberculosis among Korean adults. JAMA network open. 2021 Sep 1;4(9):e2126099.
9. Yu, X., Li, L., Xia, L., Feng, X., Chen, F., Cao, S. and Wei, X., 2019. Impact of metformin on the risk and treatment outcomes of tuberculosis in diabetics: a systematic review. BMC infectious diseases, 19, pp.1-11.
10. Zayar, N.N., Chotipanvithayakul, R., Bjertness, E., Htet, A.S., Geater, A.F. and Chongsuvivatwong, V., 2023. Vulnerability of NCDs and Mediating Effect of Risk Behaviors Among Tuberculosis Patients and Their Household Contacts Compared to the General Population in the Yangon Region, Myanmar. International Journal of General Medicine, pp.5909-5920.
11. Zelner, J.L., Murray, M.B., Becerra, M.C., Galea, J., Lecca, L., Calderon, R., Yataco, R., Contreras, C., Zhang, Z., Manjourides, J. and Grenfell, B.T., 2016. Identifying hotspots of multidrug-resistant tuberculosis transmission using spatial and molecular genetic data. The Journal of infectious diseases, 213(2), pp.287-294.
12. Zhang, X., Chen, P. and Xu, G., 2022. Update of the mechanism and characteristics of tuberculosis in chronic kidney disease. Wiener klinische Wochenschrift, 134(13), pp.501-510.
13. Zhang, C., Liu, Y., Yao, Y., Gong, D., Lei, R., Xia, Y., Xu, C., Chen, H., Cheng, J. and Zhang, H., 2024. Tuberculosis infection among close contacts of patients with pulmonary tuberculosis in China: a population-based, multicentered study. Clinical Microbiology and Infection, 30(9), pp.1176-1182.
14. Zhao, L., Fan, K., Sun, X., Li, W., Qin, F., Shi, L., Gao, F. and Zheng, C., 2024. Host-directed therapy against mycobacterium tuberculosis infections with diabetes mellitus. Frontiers in Immunology, 14, p.1305325.
15. Zhao, L., Gao, F., Zheng, C. and Sun, X., 2024. The impact of optimal glycemic control on tuberculosis treatment outcomes in patients with diabetes mellitus: systematic review and meta-analysis. JMIR Public Health and Surveillance, 10, p.e53948.
16. Zheng, C., Hu, M. and Gao, F., 2017. Diabetes and pulmonary tuberculosis: a global overview with special focus on the situation in Asian countries with high TB-DM burden. Global health action, 10(1), p.1264702.
17. Zhou, G., Guo, X., Cai, S., Zhang, Y., Zhou, Y., Long, R., Zhou, Y., Li, H., Chen, N. and Song, C., 2023. Diabetes mellitus and latent tuberculosis infection: an updated meta-analysis and systematic review. BMC Infectious Diseases, 23(1), p.770.

 

Referensi Tuberkulosis C

1. Cadena, J., Rathinavelu, S., Lopez-Alvarenga, J.C. and Restrepo, B.I., 2019. The re-emerging association between tuberculosis and diabetes: lessons from past centuries. Tuberculosis, 116, pp.S89-S97.
2. Carr, B.Z., Briganti, E.M., Musemburi, J., Jenkin, G.A. and Denholm, J.T., 2022. Effect of chronic kidney disease on all-cause mortality in tuberculosis disease: an Australian cohort study. BMC Infectious Diseases, 22(1), p.116.
3. Cegielski, J.P. and McMurray, D.N., 2004. The relationship between malnutrition and tuberculosis: evidence from studies in humans and experimental animals. The international journal of tuberculosis and lung disease, 8(3), pp.286-298.
4. Chakhaia, T., Blumberg, H.M., Kempker, R.R., Luo, R., Dzidzikashvili, N., Chincharauli, M., Tukvadze, N., Avaliani, Z., Stauber, C. and Magee, M.J., 2025. Lack of weight gain and increased mortality during and after treatment among adults with drug-resistant tuberculosis: a retrospective cohort study in Georgia, 2009–2020. ERJ Open Research.
5. Chan, P.C., Chiang, C.Y., Lee, P.H., Lo, H.Y., Chu, P.W., Chen, J.J., Kato, S. and Raviglione, M.C.B., 2025. Assessing the impact of the TB response in Taiwan–the journey towards ending TB. IJTLD open, 2(5), pp.251-259.
6. Chang, J.T., Dou, H.Y., Yen, C.L., Wu, Y.H., Huang, R.M., Lin, H.J., Su, I.J. and Shieh, C.C., 2011. Effect of type 2 diabetes mellitus on the clinical severity and treatment outcome in patients with pulmonary tuberculosis: a potential role in the emergence of multidrug-resistance. Journal of the Formosan Medical Association, 110(6), pp.372-381.
7. Charles, F., Lin, Y.D., Greig, J., Gurra, S., Morikawa, R., Graham, S.M. and Maha, A., 2024. Loss to follow-up among adults with drug-resistant TB in Papua New Guinea. Public Health Action, 14(3), pp.85-90.
8. Chaubey, G.K., Modanwal, R., Dilawari, R., Talukdar, S., Dhiman, A., Chaudhary, S., Patidar, A., Raje, C.I. and Raje, M., 2024. Chronic hyperglycemia impairs anti-microbial function of macrophages in response to Mycobacterium tuberculosis infection. Immunologic Research, 72(4), pp.644-653.
9. Chaw, L., Liew, S.Q. and Wong, J., 2022. Association between climate variables and pulmonary tuberculosis incidence in Brunei Darussalam. Scientific Reports, 12(1), p.8775.
10. Chaw, L., Hamid, R.A., Koh, K.S. and Thu, K., 2022. Contact investigation of tuberculosis in Brunei Darussalam: Evaluation and risk factor analysis. BMJ open respiratory research, 9(1).
11. Chaw L, Jeludin NH, Thu K. Prevalence and risk factors associated with tuberculosis mortality in Brunei Darussalam. Asian Pac J Trop Med 2023; 16(1): 9-15.
12. Chee, C.B.E., Kyi-Win, K., Tan, S. and Wang, Y.T., 2025. QuantiFERON-TB Gold Plus CD8+ T cell responses in contacts with tuberculosis disease and recent tuberculosis infection. Microbiology Spectrum, 13(12), pp.e01353-25.
13. Chen, C.C., Chiang, C.Y., Pan, S.C., Wang, J.Y. and Lin, H.H., 2015. Health system delay among patients with tuberculosis in Taiwan: 2003–2010. BMC infectious diseases, 15, pp.1-9.
14. Chen, Z., Liu, Q., Song, R., Zhang, W., Wang, T., Lian, Z., Sun, X. and Liu, Y., 2021. The association of glycemic level and prevalence of tuberculosis: a meta-analysis. BMC Endocrine Disorders, 21(1), p.123.
15. Chen, J., Zha, S., Hou, J., Lu, K., Qiu, Y., Yang, R., Li, L., Yang, Y. and Xu, L., 2022. Dose–response relationship between body mass index and tuberculosis in China: a population-based cohort study. BMJ open, 12(3), p.e050928.
16. Chen, S., Zhang, W., Zheng, Z., Shao, X., Yang, P., Yang, X. and Nan, K., 2023. Unraveling genetic causality between type 2 diabetes and pulmonary tuberculosis on the basis of Mendelian randomization. Diabetology & Metabolic Syndrome, 15(1), pp.1-9.
17. Chen, X., Zhou, J., Yuan, Q., Zhang, R., Huang, C. and Li, Y., 2024. Challenge of ending TB in China: tuberculosis control in primary healthcare sectors under integrated TB control model–a systematic review and meta-analysis. BMC Public Health, 24(1), p.163.
18. Chen, R.T., Liu, C.Y., Lin, S.Y., Shu, C.C. and Sheng, W.H., 2024. The prevalence, clinical reasoning and impact of non-standard anti-tuberculosis regimens at the initial prescription. Scientific Reports, 14(1), p.5631.
19. Chen, S.Y., 2024. Trends and annual percentage changes in tuberculosis mortality estimated by Joinpoint regression and age-period-cohort analyses, Taiwan, 1978–2022. Scientific Reports, 14(1), p.29101.
20. Chew, Y.R., Tay, J.Y., Kyaw, W.M., Chia, P.Y. and Ng, D.H.L., 2025. Subclinical disease among people with culture-confirmed pulmonary tuberculosis in Singapore-a retrospective study. International Journal of Infectious Diseases, 153, p.107768.
21. Chiang CY, Bai KJ, Lin HH, Chien ST, Lee JJ, Enarson DA, et al. (2015) The Influence of Diabetes, Glycemic Control, and Diabetes-Related Comorbidities on Pulmonary Tuberculosis. PLoS ONE 10(3): e0121698. doi:10.1371/journal. pone.0121698.
22. Chidambaram, V., Gupte, A., Wang, J.Y., Golub, J.E. and Karakousis, P.C., 2021. The impact of hypertension and use of calcium channel blockers on tuberculosis treatment outcomes. Clinical Infectious Diseases, 73(9), pp.e3409-e3418.
23. Chien, Y.C., Chang, C.H., Shu, C.C., Wang, H.C. and Yu, C.J., 2025. Adherence to Tuberculosis Infection Treatment and its Impact on Prevention of Tuberculosis Reactivation: A Retrospective Cohort Study from Taiwan. Journal of Infection and Public Health, p.102917.
24. Choi, H., Yoo, J.E., Han, K., Choi, W., Rhee, S.Y., Lee, H. and Shin, D.W., 2021. Body mass index, diabetes, and risk of tuberculosis: a retrospective cohort study. Frontiers in nutrition, 8, p.739766.
25. Choi, H., Han, K., Jung, J.H., Park, S.H., Kim, S.H., Kang, H.K., Sohn, J.W., Shin, D.W. and Lee, H., 2023. Long-term mortality of tuberculosis survivors in Korea: a population-based longitudinal study. Clinical Infectious Diseases, 76(3), pp.e973-e981.
26. Chu, A.L., Lecca, L.W., Calderón, R.I., Contreras, C.C., Yataco, R.M., Zhang, Z., Becerra, M.C., Murray, M.B. and Huang, C.C., 2021. Smoking cessation in tuberculosis patients and the risk of tuberculosis infection in child household contacts. Clinical Infectious Diseases, 73(8), pp.1500-1506.
27. Chung, C., Lee, K.N., Han, K., Park, J., Shin, D.W. and Lee, S.W., 2024. Association between alcohol consumption and risk of developing tuberculosis in patients with diabetes: a nationwide retrospective cohort study. Respiratory Research, 25(1), p.420.
28. Chung, E., Jeong, D., Mok, J., Jeon, D., Kang, H.Y., Kim, H., Kim, H., Choi, H. and Kang, Y.A., 2024. Relationship between metformin use and mortality in tuberculosis patients with diabetes: a nationwide cohort study. The Korean Journal of Internal Medicine, 39(2), p.306.
29. Chung, C., Lee, S.W., Jeong, D., Choi, H., Sohn, H., Jeon, D. and Kang, Y.A., 2025. Disagreement on estimating cause of death under tuberculosis treatment between the national tuberculosis registry and statistics data in South Korea, 2011–2020. Journal of Infection and Public Health, 18(5), p.102723.
30. Clark, R.A., Mukandavire, C., Portnoy, A., Weerasuriya, C.K., Deol, A., Scarponi, D., Iskauskas, A., Bakker, R., Quaife, M., Malhotra, S. and Gebreselassie, N., 2023. The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study. The Lancet Global Health, 11(4), pp.e546-e555.
31. Clearesta, K.E., Mayangsari, A.S.M., Wati, D.K., Purniti, N.P.S., Suwarba, I.G.N.M. and Artana, I.W.D., 2024. Occurence and risk factors of tuberculosis infection in orphanage children in Bali. Paediatrica Indonesiana, 64(2), pp.152-9.

Referensi Tuberkulosis N-Q

1. Nabi, S.G., Aziz, M.M., Uddin, M.R., Tuhin, R.A., Shuchi, R.R., Nusreen, N., Jahan, R., Afroz, F. and Islam, M.S., 2024. Nutritional status and other associated factors of patients with tuberculosis in selected urban areas of Bangladesh. Well Testing Journal, 33(S2), pp.571-590.
2. Ngo, M.D.; Bartlett, S.; Ronacher, K. Diabetes-Associated Susceptibility to Tuberculosis: Contribution of Hyperglycemia vs. Dyslipidemia. Microorganisms 2021, 9, 2282.
3. Nguyen, T.A., Teo, A.K.J., Zhao, Y., Quelapio, M., Hill, J., Morishita, F., Marais, B.J. and Marks, G.B., 2024. Population-wide active case finding as a strategy to end TB. The Lancet regional health. Western Pacific, 46, p.101047.
4. Njelita, I.A., Nwachukwu, C.C., Eyisi, I.G., Ezenyeaku, C.A. and Okeke, H.N., 2025. Prevalence and risk factors of active tuberculosis disease in contacts of tuberculosis cases treated in a teaching hospital in southeast Nigeria: a cross-sectional study. International Journal of Healthcare Sciences, 13(1), pp.80-89.
5. Njiro, B.J., Kisonga, R., Joachim, C., Sililo, G.A., Nkiligi, E., Ibisomi, L., Chirwa, T. and Francis, J.M., 2024. Epidemiology and treatment outcomes of recurrent tuberculosis in Tanzania from 2018 to 2021 using the National TB dataset. PLOS Neglected Tropical Diseases, 18(2), p.e0011968.
6. Noviyani, A., Nopsopon, T. and Pongpirul, K., 2021. Variation of tuberculosis prevalence across diagnostic approaches and geographical areas of Indonesia. PLoS One, 16(10), p.e0258809.
7. Nugrahaeni, D.K., Kusumasari, I., Budiana, T.A., and Mauliku, N.E. (2025). Factors Associated with Tuberculosis-Diabetes Mellitus Comorbidity. Periodic Epidemiology Journal/Jurnal Berkala Epidemiologi, 13(1):75-84.
8. Nuraisyah, F., Juliana, N., Astaria, D., Khalisah, N., Al Fatih, D.M.F., Dewi, S.K. and Marwati, T., 2024. Risk Factors of Pulmonary Tuberculosis in Type 2 Diabetes Mellitus in Yogyakarta. Journal of Epidemiology and Public Health, 9(2), pp.194-203.
9. Nwokoye, N., Odume, B., Nwadike, P., Anaedobe, I., Mangoro, Z., Umoren, M., Ogbudebe, C., Chukwuogo, O., Useni, S., Nongo, D. and Eneogu, R., 2024. Impact of the stool-based Xpert test on childhood tuberculosis diagnosis in selected states in Nigeria. Tropical Medicine and Infectious Disease, 9(5), p.100.
10. Ockenga, J., Fuhse, K., Chatterjee, S., Malykh, R., Rippin, H., Pirlich, M., Yedilbayev, A., Wickramasinghe, K. and Barazzoni, R., 2023. Tuberculosis and malnutrition: the European perspective. Clinical Nutrition, 42(4), pp.486-492.
11. Oliveira Hashiguchi, L., Cox, S.E., Edwards, T. et al. How can tuberculosis services better support patients with a diabetes co-morbidity? A mixed methods study in the Philippines. BMC Health Serv Res 23, 1027 (2023). https://doi.org/10.1186/s12913-023-10015-7.
12. Oliveira Hashiguchi, L., Ferrer, J.P., Suzuki, S., Faguer, B.N., Solon, J.A., Castro, M.C., et al. (2024). Glycemic control during TB treatment among Filipinos: The Starting Anti-Tuberculosis Treatment Cohort Study. PLOS Global Public Health, 4(5), e0003156. 
13. Omar, N., Wong, J., Thu, K., Alikhan, M.F. and Chaw, L., 2021. Prevalence and associated factors of diabetes mellitus among tuberculosis patients in Brunei Darussalam: a 6-year retrospective cohort study. International Journal of Infectious Diseases, 105, pp.267-273.
14. Oxlade, O., Benedetti, A., Adjobimey, M., Alsdurf, H., Anagonou, S., Cook, V.J., Fisher, D., Fox, G.J., Fregonese, F., Hadisoemarto, P. and Hill, P.C., 2021. Effectiveness and cost-effectiveness of a health systems intervention for latent tuberculosis infection management (ACT4): a cluster-randomised trial. The Lancet Public Health, 6(5), pp.e272-e282.
15. Pan, S.C., Ku, C.C., Kao, D., Ezzati, M., Fang, C.T. and Lin, H.H., 2015. Effect of diabetes on tuberculosis control in 13 countries with high tuberculosis: a modelling study. The lancet Diabetes & endocrinology, 3(5), pp.323-330.
16. Pan S-C, Chen Y-C, Wang J-Y, Sheng W-H, Lin H-H, Fang C-T, et al. (2015) Tuberculosis in Healthcare Workers: A Matched Cohort Study in Taiwan. PLoS ONE 10(12): e0145047.
17. Pan, S.C., Chen, C.C., Chiang, Y.T., Chang, H.Y., Fang, C.T. and Lin, H.H., 2016. Health care visits as a risk factor for tuberculosis in Taiwan: a population-based case–control study. American journal of public health, 106(7), pp.1323-1328.
18. Pando, C., Hazel, A., Tsang, L.Y., Razafindrina, K., Andriamiadanarivo, A., Rabetombosoa, R.M., Ambinintsoa, I., Sadananda, G., Small, P.M., Knoblauch, A.M. and Rakotosamimanana, N., 2023. A social network analysis model approach to understand tuberculosis transmission in remote rural Madagascar. BMC Public Health, 23(1), p.1511.
19. Pardeshi, G., Mave, V., Gaikwad, S., Kadam, D., Barthwal, M., Gupte, N., Atre, S., Deshmukh, S., Golub, J.E. and Gupte, A., 2024. Glycated Hemoglobin Trajectories and Their Association With Treatment Outcomes Among Patients With Pulmonary TB in India: A Prospective Cohort Study. Chest, 165(2), pp.278-287.
20. Park, S.W., Shin, J.W., Kim, J.Y., Park, I.W., Choi, B.W., Choi, J.C. and Kim, Y.S., 2012. The effect of diabetic control status on the clinical features of pulmonary tuberculosis. European journal of clinical microbiology & infectious diseases, 31, pp.1305-1310.
21. Park, S., Lee, S., Kim, Y., Lee, Y., Kang, M.W., Cho, S., Han, K., Han, S.S., Lee, H., Lee, J.P. and Joo, K.W., 2019. Association of CKD with incident tuberculosis. Clinical Journal of the American Society of Nephrology, 14(7), pp.1002-1010.
22. Patel, D.G., Baral, T., Kurian, S.J., Malakapogu, P., Saravu, K. and Miraj, S.S., 2024. Nutritional status in patients with tuberculosis and diabetes mellitus: A comparative observational study. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 35, p.100428.
23. Peng, Y.F., 2023. Pulmonary tuberculosis and diabetes mellitus: Epidemiology, pathogenesis and therapeutic management. Medicine International, 4(1), p.1-4.
24. Penyami, Y., Angkasa, M.P. and Sumarni, S., 2025. Using storybooks to enhance health awareness among schoolchildren at risk of tuberculosis. Malahayati International Journal of Nursing and Health Science, 7(11), pp.1338-1343.
25. Petruccioli, E., Scriba, T.J., Petrone, L., Hatherill, M., Cirillo, D.M., Joosten, S.A., Ottenhoff, T.H., Denkinger, C.M. and Goletti, D., 2016. Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis. European Respiratory Journal, 48(6), pp.1751-1763.
26. Pradana, T.L.C., Putra, B.T.W. and Utami, W.S., 2025. Stigma Tuberkulosis Paru di Asia Tenggara: Systematic Literatur Review. MAHESA: Malahayati Health Student Journal, 5(6), pp.2501-2512.
27. Pramono, J.S., Ridwan, A., Maria, I.L., Syam, A., Russeng, S.S. and Mumang, A.A., 2024. Active case finding for tuberculosis in migrants: a systematic review. Medical Archives, 78(1), p.60.
28. Pratiwi, R.D., Alisjahbana, B., Subronto, Y.W., Priyanta, S. and Suharna, S., 2025. Implementation of an information system for tuberculosis in healthcare facilities in Indonesia: evaluation of its effectiveness and challenges. Archives of Public Health, 83(1), pp.1-18.
29. Puyat, J.H., Brode, S.K., Shulha, H., Romanowski, K., Menzies, D., Benedetti, A., Duchen, R., Huang, A., Fang, J., Macdonald, L. and Marras, T.K., 2025. Predicting Risk of Tuberculosis (TB) Disease in People Who Migrate to a Low-TB Incidence Country: Development and Validation of a Multivariable, Dynamic Risk-Prediction Model Using Health Administrative Data. Clinical Infectious Diseases, 80(3), pp.644-652.
30. Qi, M., Qiao, R. and He, J.Q., 2025. The association between triglyceride-glucose index and related parameters and risk of tuberculosis infection in American adults under different glucose metabolic states: a cross-sectional study. BMC Public Health, 25(1), pp.1-11.
31. Qi, X., Yang, Q., Cai, J., Wu, J., Gao, Y., Ruan, Q., Shao, L., Liu, J., Zhou, X., Zhang, W. and Jiang, N., 2024. Transcriptional profiling of human peripheral blood mononuclear cells in household contacts of pulmonary tuberculosis patients provides insights into mechanisms of Mycobacterium tuberculosis control and elimination. Emerging Microbes & Infections, 13(1), p.2295387.